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ABSTRACT 
Factors Influencing Intention to Obtain a Genetic Test for Prostate Cancer Risk:  
A Structural Equation Modeling Approach 
Melissa K. Wayne 
J. Michael Williams, PhD 
 
 
 
As men age, they are faced with many health-related decisions. One particular 
area of focus is prostate cancer, since it is the most common type of cancer in men in the 
United States and it is highly curable if detected early. Although there is currently no 
genetic test for prostate cancer risk, its development is in progress, and multiple genes are 
implicated in the onset and progression of the disease. Since genetic testing may someday 
be used to tailor cancer prevention based on an individual’s genotype, there is a need to 
better understand men’s interest in testing for prostate cancer susceptibility.  A fuller 
understanding of this decision-making process may help increase participation in 
screening behaviors and thereby increase early detection and survival.  
The present study investigated the roles played by patient characteristics, health 
related quality of life, beliefs about benefits, concerns about consequences, and 
family/social influences on men’s intentions to undergo genetic testing as a preventive 
measure for prostate cancer. This study proposed that men’s stated intention to undergo 
genetic testing for prostate cancer would be primarily distally related to 
sociodemographic characteristics and proximally related to beliefs, concerns, and 
influence.  
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Structural Equation Modeling was performed in order to provide an intricate 
conceptual and explanatory framework describing how intention can be predicted by 
testing the intercorrelations, and both direct and indirect effects of the variables.  
The overall predictions were generally supported by the analysis. Demographic 
characteristics such as income, age, and education, and health related quality of life were 
distally related to intention and they were mediated by beliefs in benefits, concerns, and 
commitment to one’s decision/tendency to resist influence by social network. Men’s level 
of commitment to their decision was found to have the strongest influence on intention to 
test in the current model. In addition, family history was not found to significantly 
influence intent, concerns, or benefits, all of which were originally hypothesized. 
Results suggest several implications for the informed consent process including 
the use of a psychoeducational model incorporating information about risks and benefits 
of testing. Limitations and future directions are discussed.  
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CHAPTER 1: INTRODUCTION 
 
 Patient decision-making is a vital part of prevention of many serious illnesses. In 
fact, it is not only relevant to prevention of disease, but it is also related to most health-
protective and preventive behavior (Goldring, Taylor, Kemeny, & Anton, 2002). As men 
age, they are faced with many health-related decisions. One particular area of focus is 
prostate health, since prostate cancer is the most common type of cancer in men in the 
United States (Wong, Stewart, Dancey, Meana, McAndrews, Bunston, & Cheung, 2000). 
In 2004, it is estimated that prostate cancer will comprise 33% (230,110 cases) of cancers 
diagnosed in men in North America (American Cancer Society, 2004). In addition, it is 
the second most common cause of death  related to cancer (Wong et al., 2000; Nieder, 
Taneja, Zeegers, & Ostrer, 2003) and it is estimated that 29,500 men (10% of all cancer 
deaths) will die from prostate cancer in the year 2004 in the United States alone (ACS, 
2004).   
With this knowledge, and with recent scientific developments, patients have been 
faced with the challenge of deciding just how much information they wish to acquire. It 
appears likely that genetic testing for cancer susceptibility may be used in the future to 
tailor prevention efforts, thus indicating a need to understand how people decide to 
engage in the decision-making process (Lerman & Shields, 2004). Through the mapping 
of the human genome and the Human Genome Project, the level of knowledge about 
genetic aspects of various diseases has skyrocketed (genome.gov, 2004).  The cloning of 
genes associated with multiple types of cancer has led to studies of mutations that help to 
determine patients’ relative susceptibility to each disease (Bluman, Rimer, Sterba, 
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Lancaster, Clark, Borstelmann, Inglehart, & Winer, 2003). This genetic knowledge offers 
a glimpse into the heritable aspects of the complex relationship between biology, 
behavior, and environment in the development of cancer (Baum, Friedman, & Zakowski, 
1997).  Although there is currently no genetic test available for prostate cancer risk, its 
development is in progress, and multiple genes are implicated in the onset and the 
progression of the disease (Cancer.gov, 2004).   Due to this progress, it is becoming 
important to learn how men’s beliefs and characteristics will influence their intentions to 
obtain such genetic information in order to help increase participation in genetic testing 
and screening behavior.  
The emerging literature points to a number of factors that are likely to be 
influential in the decision-making process for genetic testing. These factors include 
sociodemographic characteristics, beliefs about benefits and consequences of testing, 
health related quality of life, and family and social influence.  For example, perceived 
benefits have been shown to positively correlate with intention to undergo genetic testing  
for various types of cancer in both the general population and in high-risk individuals 
(Jacobsen, Valdimarsdottir, Brown, & Offit, 1997; Martinez, 2002; Lerman, Narod, 
Schulman, Hughes, Gomez-Caminero, Bonney, Gold, Trock, Main, Lynch, Fulmore, 
Snyder, Lemon, Conway, Tonin, Lenoir, & Lynch, 1996; Lerman, Biesecker, 
Benkendorf, Kerner, Gomez-Caminero, Hughes, & Reed, 1997).  Studies also suggest 
that known family history of prostate cancer often predicts intention to undergo testing 
for related mutations (Lerman et al., 1996; Cormier Valeri, Azzouzi, Fournier, Cussenot, 
Berhon, Guillermin, & Mangin, 2002; Jacobsen, Lamonde, Honour, Kash, Hudson, & 
Pow-Sang, 2004; Bosompra, Ashikaga, Flynn, Worden, & Solomon, 2001).  
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 In addition, income, level of education, and age, have all been shown to be 
predictive of intention to test. Higher income or socioeconomic status has been shown to 
predict a greater likelihood of stated intention to undergo testing, and more educated 
individuals have been found to be more inclined to test for mutations than less educated 
individuals (Lerman, Hughes, Trock, Myers, Main, Bonney, Abbaszadegan, Harty, 
Franklin, Lynch, & Lynch, 1999; Lerman et al., 1996; Bosompra et al., 2001; Arora & 
McHorney, 2000). In the majority of studies, age was found to positively correlate with 
intention to undergo testing for genetic mutations (Doukas, Fetters, Coyne, & 
McCullogh, 2000; Glanz, Grove, Lerman, Gotay, & LeMarchand, 1999). However, some 
studies point to an inverse correlation between men’s age and intention to undergo 
genetic testing, which has been explained by the theory that older men are more skeptical 
or that they prefer a less active role in their personal medical decisions (Arora & 
McHorney, 2000; Myers, Hyslop, Jennings-Dozier, Wolf, Burgh, Diehl, Lerman, & 
Chodak, 2000).  
There also exists a significant amount of support for the notion that insurance 
status and concerns about insurance and employment discrimination influence decision to 
undergo testing. People without insurance or with more concerns about confidentiality 
and insurance coverage have been shown to be less likely to state intention to undergo 
genetic testing for cancer risk. Many studies suggest that those concerns are significant 
barriers to testing for cancer genes in high risk groups (Peterson, Milliron, Lewis, Goold, 
& Marajver, 2002; Lerman et al., 1996; Kinney, DeVellis, Skrzynia, & Millikan, 2001).  
However, there appear to be some significant deficits in the current literature and 
it only provides a limited explanation of this complex decision-making process.  For 
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example, there is a great deal of literature available about the psychological and 
emotional impact of genetic testing, but there are significantly fewer studies focused on 
the anticipated emotional responses. Whether or not there are significant emotional 
consequences of genetic testing, the decision would likely be influenced by an 
individual’s concern about experiencing those consequences. The literature that does 
exist points to this concept as well (Jacobsen et al., 1997; Bleiker, Hahn, & Aaronson, 
2003).  
To date, there is only a limited understanding of how family/social network 
influences men’s test intention. Although there is a significant amount of literature 
related to social support in medical decision-making, there are just a few studies 
involving the influence of family and social network on the decision-making process. 
However, the majority of those studies report a significant impact on decision-making by 
social network (Glanz et al., 1999; Champion, 1989; Coyne & Anderson, 1999). That is, 
there is little research citing the influence of the stated judgments of family, friends, and 
others on intention to undergo testing. In fact, Lerman, Croyle, Tercyak, & Hamann, 
(2002), specifically note that family influence and support has not been thoroughly 
addressed in the literature and that it is important to view genetic testing decisions in the 
context of the family. The literature is also lacking a dynamic model describing how 
these family and social influence factors may mediate or moderate the influence of men’s 
sociodemographic characteristics and their beliefs about benefits and consequences of 
undergoing genetic testing for prostate cancer risk.  A fuller understanding of this 
complex process, particularly of the roles played by family and social support, is essential 
for patient-centered genetic consultation and for psychological counseling in general.     
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The interaction and influence of these factors is of particular clinical interest, and 
men faced with genetic testing decisions can often find themselves feeling quite 
conflicted about their decision. For example, if family members or members of the social 
network feel strongly that a man should not undergo testing, but the man sees significant 
benefits to testing, he is likely to become more concerned and to have a more difficult 
time making a decision.  Another scenario might include a man with a family history of 
prostate cancer who has a great deal of concern about consequences of testing and a 
family who strongly believes that he should be tested. This man would also be likely to 
feel conflicted when making decisions. These are clearly just two of many examples of 
clinically relevant scenarios that might indicate a need for psychosocial intervention. The 
model presented in the current study will likely be a useful tool for clinicians to use to 
guide treatment and to target specific areas for intervention.  
Methodologically, the majority of studies to date primarily rely on multiple 
regression methods in modeling behavior, with few using a more complex multivariate 
methodology capable of providing a more detailed explanation of the variables. These 
methods are powerful, although they are somewhat limited in describing the complex 
interactions between correlated independent variables. The current investigation employs 
Structural Equation Modeling, which provides a more intricate conceptual and 
explanatory framework by testing intercorrelations and both mediating and moderating 
effects of the variables, thereby capturing more of this complex decision-making process. 
Most models are not as dynamic and do not afford this level of complexity and the ability 
to test direct and indirect effects of the variables.  Moreover, two latent psychological 
constructs are hypothesized to drive test intention and are incorporated into the model.  
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One latent construct relates to men’s concerns about consequences of testing (e.g., 
concerns about the misuse of genetic information and about future insurability; and 
concerns about the emotional impact of testing).  The other is related to men’s propensity 
to be influenced by the wishes of others within different levels of their family and social 
support network. Thus, this model will likely help to elucidate the roles played by the 
demographic and belief variables and help to clarify their complex relationships relative 
to predicting intention to undergo genetic testing.  
 
Rationale 
Men between the ages of 40 and 70 years have a host of potential medical 
concerns to attend to. In fact, the risk of developing prostate cancer increases with age 
and is likely to impact the lives of many men in this age range.  The survival rates for 
cancers detected early are nearly 100% and they decrease significantly when the 
diagnosis comes at a later stage (ACS, 2004). Thus, long-term survival of prostate cancer 
hinges on early detection and participation in screening behaviors. With the recent 
identification of genes linked to prostate cancer, new knowledge will soon be available in 
the fight against the disease. Genetic information provided by a genetic test for prostate 
cancer risk, when it becomes available, will not provide definitive answers about whether 
a person will develop prostate cancer, but a positive test will indicate risk significantly 
higher than that of the general population (Genome.gov, 2004).   In the face of this 
uncertainty, the purpose of this investigation is to help discover which factors contribute 
to deciding whether to test for genetic links to prostate cancer. A fuller understanding of 
this decision-making process will help inform the decision-making process and perhaps 
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increase participation in screening behaviors and thereby increase early detection and 
survival. 
Thus, personal decision-making is relevant to survivorship of prostate cancer and 
is therefore of interest to psychologists and primary care providers, in order to maintain 
the vigilance likely required to detect cancer early. Because belief systems are known to 
predict health behavior, constructs of interest include beliefs about benefits, concerns 
about consequences, and health related quality of life. In addition, another focus of this 
investigation is the influence of family and others on decision-making. Based on this 
impact, there will likely be significant implications for psychologists, family therapists, 
physicians, and genetic counselors to include the family in the educational and decision-
making processes.  
In the next chapter, general information about the clinical aspects of prostate 
cancer will be provided, and then the current literature on the genetics of prostate cancer 
will be described.  Next, a review of the literature pertaining to beliefs will be presented, 
along with a description of the Health Belief Model.  This will include health related 
quality of life, beliefs about consequences, beliefs about benefits, and the relationship of 
intention to actual behavior. Literature related to specific demographic characteristics 
will also be reviewed.  
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CHAPTER 2: LITERATURE REVIEW 
 
Prostate Cancer 
 Cancer of the prostate, as stated above, is expected to be the most frequently 
diagnosed cancer in men in the year 2004 (ACS, 2004).  The following section provides a 
review of the signs and symptoms of prostate cancer, commonly known risk factors, 
detection information, and survival rates.  
 
Signs and Symptoms 
 There are usually no signs or symptoms of early prostate cancer. However, as the 
cancer becomes more advanced, patients might experience decreased flow of urine, 
inability to urinate, difficulty starting or stopping flow of urine, a need to urinate 
frequently particularly at night, blood in the urine, pain or burning during urination, or 
continual pain in the lower back, upper thighs, or pelvis (ACS, 2004). Many symptoms 
can seem innocuous, nonspecific, or similar to symptoms of other less serious conditions. 
Since prostate cancer is much more curable in early stages, though, it is important to 
engage in screening behavior rather than wait for these symptoms to become noticeable.  
 
Commonly Known Risk Factors 
 The only well-known and established risk factors for prostate cancer are age, 
ethnicity, and family history of prostate cancer (Jemal, Murray & Samuels, 2003). Over 
70% of prostate cancer diagnoses occur in men over the age of 65. Internationally, 
African-American men and Jamaican men of African descent are known to be at highest 
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risk. They are also known to be the least likely ethnic group to engage in prostate cancer 
screening (Weinrich, Holdford, Boyd, Creanga, Cover, Johnson, Stromberg, & Weinrich, 
1998). The risk of developing prostate cancer in African-American men based purely on 
ethnicity is estimated to be 40-80% greater than the risk for Caucasian men (Nieder et al., 
2003).  In addition, some studies suggest that dietary fat consumption might also 
contribute to increased risk (ACS, 2004).   A positive family history has been found to be 
a significant risk factor for prostate cancer (Nieder et al., 2003). Recent studies suggest 
that 5-10% of prostate cancers correlate with a strong family predisposition, suggesting a 
genetic/environmental link (ACS, 2004). This issue will be addressed.   
 
Detection 
 Early detection of prostate cancer is crucial to longer term survival and it can 
significantly reduce mortality rates (Weinrich et al., 1998). Two primary modes of 
detection and screening are the Prostate Specific Antigen (PSA) test, and the Digital 
Rectal Exam (DRE). The PSA test is a blood test that detects a substance created by the 
prostate gland called prostate specific antigen. According to the American Cancer 
Society, both should generally be offered yearly to men after the age of fifty years. They 
suggest that it be offered to African-American men or men with a first-degree relative 
who has been diagnosed with prostate cancer at the age of forty-five years (ACS, 2004). 
The American Urological Association recommends PSA and DRE screening yearly after 
age fifty for men in the general population and after age forty for men in high-risk 
categories (Nieder et al., 2003).  
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Treatment 
 The options for treatment depend on age, staging, and the presence of other 
illnesses. Treatment is frequently invasive and can cause long-term complications such as 
incontinence or impotence (Krahn, Mahoney, Eckman, Trachtenberg, Pauker, & Detsky, 
1994). For early-stage disease, surgery, such as radical prostatectomy, and radiation are 
among the more common forms of treatment. Chemotherapy, radiation, and hormone 
therapy are common in various combinations for metastatic or more advanced phases of 
the disease. Chemotherapy and hormone therapy can be utilized in treating earlier stages 
of disease as well. Hormone therapy can help to reduce pain by shrinking tumors. For 
older individuals, those with less aggressive disease, or those with a shorter life 
expectancy, “watchful waiting” is often employed. This entails close monitoring and no 
treatment (ACS, 2004). 
For those men who undergo radical prostatectomy, studies have found that they 
experience substantial declines in sexual and urinary function (Schapira, Lawrence, Katz, 
McAuliffe, & Nattinger, 2001). Szabo (2004) reported that prostate cancer survivors 
reported sexual functioning that was 50% lower than that reported by men without 
cancer. Although survival rates are fairly high when cancer is detected early, recent 
reports suggest that quality of life of survivors of prostate cancer who have received 
treatment is lower than previously thought (Szabo, 2004). For example, six years post 
radiation treatment, 3% of men had severe urinary incontinence and also reported bowel 
problems and sexual dysfunction (Szabo, 2004).  
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Survival 
 Survival rates for prostate cancer are relatively high, due to the high rate of early 
detection. Since 86% of prostate cancer diagnoses occur in the early stages either local or 
regional, the five year survival rate for those diagnosed early is nearly 100%. The overall 
five year survival rate is 98% which is up from 67% just twenty years ago.  The most 
recent data suggest that the ten year survival rate is 84% (ACS, 2004). Given these 
statistics, it is easy to see that early detection is critical to survival.  
 Not only is risk of prostate cancer higher in African-American men than in any 
other ethnic group, but the cancer itself is often more aggressive at presentation. In 
addition, the cancer may also not respond as well to treatment. A number of studies found 
that race independently predicts recurrence in men with prostate cancer (Nieder et al., 
2003). Thus, survival rates are also lower in African-American males.  
 
Prostate Cancer Genetics and Heritability 
Family History  
Positive family history of prostate cancer has been shown to be the strongest risk 
factor for its eventual development (Bratt, 2002, Staples, Giles, English, McCredie, 
Severi, Sui, & Hopper, 2003). Evidence from twin studies suggests that at least some of 
this elevation in risk is due to a shared genetic predisposition (Nieder et al., 2003).  
According to Nieder (2003), monozygotic/identical twins were significantly more likely 
(27.1%) than dizygotic/fraternal twins (7.1%) to both be affected with prostate cancer. 
From this study, it was estimated that genetic influence accounted for 57% of the 
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variance.  Studies of twin registries in Sweden, Denmark, and Finland have replicated 
this finding (Nieder et al, 2003).  
The term “heritable” refers to predispositions or characteristics passed on to 
children from their parents. Family history of a specific disease can then be used to 
estimate heritable risk. It is, however, imperfect in estimating risk, since many relatives 
of cancer patients neither develop the disease nor carry the genetic predisposition (Baum 
et al., 1997). 
In some families, the inheritance pattern appears similar to a dominant trait. This 
is referred to as ‘hereditary prostate cancer’ and it is defined by the following: a group of 
three or more first-degree relatives with prostate cancer, as well as prostate cancer in each 
of three generations in either maternal or paternal relatives; or two or more first or 
second-degree relatives with prostate cancer under the age of fifty-five years. However, 
having even one or two relatives diagnosed with prostate cancer can contribute to 
increased risk and is often referred to as ‘familial prostate cancer’ (Kupelian, P. A., 
Klein, E. A., Witte, J.S., Kupelian, V. A. & Suh, J.H.,1997). Level of risk has been 
shown to increase with number of relatives affected. For example, Nieder et al., (2003) 
note that an individual with one first-degree relative with prostate cancer is twice as 
likely as a man in the general population to develop prostate cancer. In addition, a Utah 
Population Database study found that first-degree relatives of persons with prostate 
cancer were more likely than the general population to develop colon cancer, non-
Hodgkin’s lymphoma, rectal cancer, and brain cancer (Goldgar, Easton, Cannon-
Albright, & Skolnick, 1994).  
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Prostate Cancer Genetics 
 It has been widely established that approximately five to ten percent of all 
prostate cancer can be accounted for by inherited high-risk genetic factors such as 
prostate cancer susceptibility genes and that 30-40% of early onset disease might be 
accounted for by these factors as well (Bratt, 2002; Stanford & Ostrander, 2001.).  As 
evidence emerges to expand the concept of familial clustering of prostate cancer to 
include specific genetic influences, the potential to understand relative risk increases.  
Current estimates suggest that if a person is found to possess one of the autosomal 
dominant mutations correlated with elevated prostate cancer risk, their lifetime risk of 
developing prostate cancer will be significantly increased (Anderson & Anderson, 1998; 
Bratt, 2002).  
 
Genes/mutations linked to prostate cancer 
Many locations on a chromosome, or loci, have been identified as linked to 
prostate cancer susceptibility. This review will provide a brief look at these identified 
mutations.  
HPC1 (hereditary prostate cancer) on Chromosome 1q24-25: This was identified 
in 1996 (ACS, 2004; Bratt, 2002). It was linked to prostate cancer in one third of North 
American and Swedish families studied in a linkage analysis study (Bratt, 2002). It was 
confirmed as a susceptibility locus in subsequent studies (Carptenc, Nupponen, Isaacs, 
Sood, Robbins, Xu, Faruque & Moses, 2002; Bratt, 2002).  Subsequent to its 
identification, information about the HPC1 region has increased dramatically and this 
remains one of the primary regions of focus for prostate cancer genes (Carptenc et al., 
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2002). Prostate cancer in families linked to HPC1 is often characterized by later stage of 
diagnosis, higher tumor grade, and earlier age at onset (Miesenfeldt, Jones, Cohn, 
Lippert, Haden, Turner, Martin-Fries, & Clark, 2000).  
PCaP (predisposing cancer susceptibility gene) on Chromosome 1q42-43: This 
was identified in 1998 by French and German researchers (Berthon, P., Valeri, A., 
Cohen-Akenine, A., Drelon, E., Paiss, T., & Wohr, G., 1998). Its link to prostate cancer 
has been replicated in Western Europe, but not in the United States (Bratt, 2002; Smith, 
Freije & Carpten, 1996.)  
HPCX on Chromosome Xq27-28: This is recessive and on the X chromosome and 
it is supported by the higher incidence in brothers than in sons of men with the disease. 
This was also reported in 1998 and it was supported by studies in both the United States 
and Finland (Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., & Nusskern, D., 1998). 
This is not a classic tumor suppressor gene; rather it acts as a tumor promoter instead of 
as an initiator.  
CAPB (cancer of the prostate and brain) on Chromosome 1p36: This 
chromosome link was found in 1999. It was found to be linked to both prostate and brain 
cancer, as the name suggests. This locus has not garnered a great deal of support in the 
research (Xu, J., Zheng, S., Chang, B., Smith, J., Carpten, J., & Stine, O.C., 1999; 
Tavtigian, Simard, & Teng, 2001).  
HPC2 (hereditary prostate cancer 2)/ELAC2 on Chromosome 17p12: This was 
identified in the year 2000 by Myriad Genetics. This was the first prostate cancer 
susceptibility gene to be cloned, but is likely only a rare cause of hereditary prostate 
cancer (Wang, McDonnell, & Elkins, 2001; Bratt, 2002).  
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HPC20 on Chromosome 20q13: This germline mutation was also identified in 
2000. It was found in 12% of hereditary prostate cancer patients in the study and the 
mutation was found to be more common among patients with later onset disease (Bratt, 
2002; Bock, Cunningham, & McDonnell, 2001).  
RNASEL(ribonuclease L) in the HPC1 region: This specific gene was identified 
by researchers at Johns Hopkins University in 2002. A mutation was found that 
inactivated the RNASEL gene. RNASEL plays a role in defending cells from viruses and 
assists in normal cell turnover, and deactivating this gene might explain why some 
prostate cells become cancerous (Carptenc et al., 2002).  
 In addition to the prostate cancer susceptibility genes, some research has 
supported the idea that men in families with mutations on the breast cancer susceptibility 
genes (BRCA1 & BRCA2) are at increased risk to develop prostate cancer.  The 
estimates of risk are not consistent, though relative risk has been shown to be 
significantly elevated. One study of Israeli men indicates that the incidence of prostate 
cancer in such families is 30% by age 80 and it is suggested that it will be characterized 
by more aggressive disease (Gjusti, Rutter, Duray, Freedman, Konichesky, Fisher-
Fischbein, Green, Maslansky, Fischbein, Gruber, Rennert, Ronchetti, Heewitt, Struewing, 
& Iscovich, 2003).  In Finland, however, this link was not found and the hereditary breast 
cancer genes were not found to play a role in hereditary prostate cancer (Ikonen, 
Matikainen, Syrjakoski, Mononen, Koivisto, Rokman, Seppala, Kallioniemi, Tammela, & 
Schleutker, 2003).  It is unlikely that this will be a primary focus for prostate cancer 
genetic testing.  
    
   
16
 Given the sheer number of loci identified in the search for the “hereditary prostate 
cancer gene”, it is important to understand why it is so difficult to identify and clone the 
genes.  First, it is likely that in different populations, there will be different genes of 
interest. Second, it is possible that some of the genes identified will turn out to be 
artifacts.  Third, the genetic mechanisms behind prostate cancer might be more complex 
than initially thought, thereby slowing the process of developing a series of genetic tests. 
There might also be genes that have not yet been identified that modify the expression or 
penetrance of the prostate cancer susceptibility genes. According to Mosby’s Pocket 
Dictionary of Medicine, Nursing, & Allied Health (1998), penetrance is defined as “the 
regularity with which an inherited trait is manifest in the person who carries the gene”.  
In addition, environmental factors are also thought to influence the development of 
hereditary prostate cancer (Staples et al., 2003; Bratt, 2002). Thus, the genetic aspects of 
prostate cancer are quite complex, but frequent new discoveries indicate that a test will 
likely be available in the near future.  
 
Goals and Consequences of Genetic Testing 
The primary goal of genetic testing for cancer is to help cancer prevention efforts 
in more susceptible populations by improving monitoring and screening, and to 
disseminate information about benefits of prophylactic surgery and chemoprevention, in 
order to reduce the number of cancer deaths (Bowen, Patenaude, & Vernon, 1999). Thus, 
the ideal outcome and primary goal of genetic testing is behavior change that would lead 
to earlier detection and better health outcomes (Lerman et al., 2002). In general, it has 
been found that interest in genetic testing for cancer risk has ranged from 45% to more 
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than 90%, depending on the targeted population (Jacobsen et al., 1997; Vernon, Gritz, 
Peterson, Perz, Marani, Amos, & Baile, 1999; Bowen et al., 1999).  
Genetic testing for cancer risk has ethical, psychological, and medical/legal 
consequences (Bratt, 2002). For example, the impact is not only on the person found to 
be a carrier of a mutation, but family members will likely be affected as well. Genetic and 
psychological counseling should target the individual and family both before and after 
testing, even if the results show no mutation related to cancer (Bratt, 2002). As cloning of 
prostate cancer susceptibility genes emerges, urologists will need to be prepared to 
present information about genetic testing, as well as information about the importance of 
environment and other genetic influences that might modify cancer risk (Bratt, 2002).  
Since primary prevention options like gene therapy or prophylactic chemotherapy are not 
available for prostate cancer, it will be the responsibility of urologists and primary care 
physicians to explain risk and appropriate screening measures in order to reduce mortality 
(Bratt, 2002).   
Some potential risks and limitations of genetic testing include uncertainty in 
actual level of risk for cancer, the lack of proven strategies in cancer prevention, risk of 
discrimination based on genetic status in both employment and insurance, and the 
potential for serious psychological impact and distress upon learning one’s status 
(Lerman et al., 1996; Milliron, Lewis, Goold, & Merajver, 2002; ASCO, 2003).  In an 
investigation about psychological responses to genetic testing for breast cancer, mutation 
carriers were found to have significantly higher levels of psychological distress and 
carriers remained more distressed than non-carriers at follow-up (Croyle, Smith, Botkin, 
Baty, & Nash, 1997; Coyne et al., 2003). However, a number of studies refute these 
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findings and further report just the opposite; that there is no long term clinically 
significant distress (Bratt, Emanuelsson, & Gronberg, 2003; Coyne, Kruus, Racioppo, 
Calzone, & Armstrong, 2003). In addition, in a study of men’s screening for prostate 
cancer, most men with a high risk for developing prostate cancer did not experience any 
severe adverse psychological effects after screening. However, genetic counseling will 
still be important in the future, in order to help address any potential psychological 
impact (Bratt et al., 2003).  
 
Health Belief Model 
The Health Belief Model (HBM) is one of most widely used explanatory models 
for preventive health behavior (van der Pligt, 1996). As with the other theories of health 
protective behavior, the Health Belief Model poses that motivation for self-protection 
comes from the anticipation of a negative health outcome and the desire to avoid or 
reduce its impact (Weinstein, 1993). This model focuses on “conscious decisions about 
the utility of specific actions and distinguishes five factors that are assumed to determine 
the adoption of protective action” (Weinstein, 1993). These factors are perceived 
susceptibility to developing a specific health problem, perceived severity of that problem, 
perceived benefits of behavioral actions, perceived barriers and/or possible negative 
consequences of the actions, and specific cues to action such as symptoms, mass media 
communications, or a health education campaign (van der Pligt, 1996). 
 It is assumed in this model, that preventive action or health protective behavior is 
most likely to occur when perceived severity, susceptibility, and perceived benefits are 
high, and costs of the behavior are low (van der Pligt, 1996).  Research has repeatedly 
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supported this model of self-protective behavior (van der Pligt, 1996; Goldring et al., 
2002; Sutherland, da Cunha, Lockwood, & Till, 1998).  Weinstein (1993) suggests that 
the HBM is not a theoretical model, but a group of unrelated constructs hypothesized to 
predict behavior, because the model, as originally conceived, does not focus on the 
interaction between the constructs themselves. It is however, a value-expectancy 
approach to health-related decision-making (Goldring et al., 2002).  
Despite the report by Weinstein, the majority of the literature continues to support 
the health belief model as a strongly predictive theoretical model of health protective 
behavior.  Goldring et al. (2002) note that changes in beliefs about severity and 
susceptibility to a health outcome are associated with motivation to take action. They 
report that health beliefs explain up to 40% of the variance in health protective behavior.    
In their study of medication-taking intention in Inflammatory Bowel Disease, 
health beliefs accounted for nearly 32% of the variance. In addition, higher perceived risk 
of disease flare-up predicted higher intention to take medication (Goldring et al., 2002). 
Jacobs (2000) conducted a study of the health belief model and intention to participate in 
cancer screening. She found support for the use of the HBM as the organizing theoretical 
model for cancer screening.     
In a study examining the direct and mediating factors that influence the likelihood 
that a person will undergo genetic testing for cancer risk in general, the HBM was used as 
a guiding model (Bosompra, Flynn, Ashikaga, Rairikar, Worder, & Solomon, 2000). 
Variables included in their study were perceived disease susceptibility, perceived 
benefits, perceived barriers, family history of cancer, awareness of the test, and 
demographic variables. They posed that likelihood would be closely linked to the belief 
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and perception variables and more distally linked to the demographic factors and they 
found support for the use of this model.  
 
Perceived benefits 
Perceived benefits and advantages have often been cited as motivators to engage 
in health protective behaviors and more specifically, to engage in genetic testing 
(Jacobsen et al., 1997; Edwards, Johnson, Mason & Boyle, 2002; Vernon et al., 1999).  
Jacobsen et al. (1997) found that women who perceived more benefits than negatives to 
genetic testing for breast cancer were more inclined to state intention to undergo testing 
for mutations. These benefits were identified as learning whether their children and other 
first-degree relatives were at risk, increased use of screening methods and aid in decision-
making about preventive measures, taking better care of oneself, and alleviating 
psychological distress.  In a study investigating the intention of African-American men to 
undergo prostate cancer screening, age, education, and perceived benefits all positively 
correlated with intention (Edwards et al., 2002). 
 One study of patients’ intention to undergo colon cancer genetic testing indicates 
that when perceived benefits, such as the belief that being tested will help family 
members prevent cancer or belief in the ability to cope with results, will outweigh costs, 
individuals are more likely to undergo genetic testing. In other studies, positive aspects 
such as perceived benefits of testing were more strongly associated with intention to 
undergo testing than were negative aspects (Vernon et al., 1999). A focus group study of 
colorectal cancer patients and their first-degree relatives found themes such as improved 
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health-related decisions, informing relatives about risk potential, and helping physicians 
make recommendations for screening (Kinney et al., 2001).   
Martinez (2002) found that intention to undergo testing increased with higher 
number of perceived benefits of testing for BRCA1/2 mutations in Hispanic women. In 
their study investigating women’s requests for test results after undergoing genetic testing 
for breast cancer risk, Lerman et al. (1997) found that requests positively correlated with 
more knowledge about testing, higher levels of pretest cancer worry and distress,  more 
perceived benefits of testing, and increased belief in the importance of benefits. In 
addition, in their prospective study of patient decision-making for BRCA1 testing, 
Lerman et al. (1996) also found that perceived benefits of testing are important predictors 
of test uptake.   
A descriptive/qualitative study investigating adults seeking genetic testing for 
Huntington’s disease, showed two significant themes related to decision-making; 
potential for negative outcomes and expected benefits (Williams, Schutte, Evers & 
Forucci, 1999). They identified these benefits as relief from uncertainty, planning for 
one’s future, and knowing if family members are at risk. They also note a fear of loss of 
family support. Perceived benefits were also found to be proximally predictive of 
intention to undergo genetic testing for cancer in the general population (Bosompra et al., 
2000). In this case, all benefits appeared to be related to helping family members.  
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Demographics and Intention 
Multiple demographic variables have been shown to influence intention to 
undergo genetic testing for cancer. In a study evaluating intention to obtain genetic 
testing for colon cancer risk, while perceived benefits and barriers had direct effects on 
intention; age, socioeconomic status, and family history had indirect effects on intention 
and were mediated by the effects of perceived benefits and barriers (Bunn, Bosompra, 
Ashikaga, Flynn, & Worden, 2002).  
 
Income 
 Level of income is associated with numerous health related behaviors. Intention to 
learn results of genetic testing for colon cancer genes has been found to positively 
correlate with income (Lerman et al., 1999). Higher income appears to predict higher 
intent to undergo genetic testing because of more security with regard to healthcare, and 
it is frequently correlated with higher education.  Patients who were offered genetic 
testing for colon cancer susceptibility were found to utilize testing more if their 
income/socioeconomic status was higher. Thus, there appeared to be a positive 
correlation between SES and test uptake (Lerman et al., 1999).  
In their study of women’s intention to undergo genetic testing for breast cancer 
genes, Lerman et al. (1996) found that higher income and more relatives with breast 
cancer positively correlated with test use. Income has also been shown to be positively 
correlated to awareness of genetic testing in general (Bosompra et al., 2001). Lower 
income men have also been found to engage in less screening behavior for prostate 
cancer (Weinrich, Ellison, Boyd, Hudson, Bradford, & Weinrich, 2000).  Weinrich et al. 
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(2000) found that even if screening is free, lower income men tend to be afraid of the 
results and the ultimate financial burden posed by the findings. In a study investigating 
barriers to genetic testing for breast cancer, Peterson et al. (2002) found that lower 
income participants were more concerned about insurance coverage and were therefore 
less inclined to engage in testing.    
 
Education 
 Level of education has been found to correlate with intention to undergo genetic 
testing in various populations. For example, Lerman et al. (1996) found that women with 
a high school education and beyond were more inclined to undergo testing for BRCA1 
mutations than were less educated women. In a study related to genetic testing for 
hereditary colon cancer genes, persons with more education and history of past utilization 
of genetic testing were more likely to undergo testing (Lerman, et al., 1999).  
In their investigation of women’s intention to receive test results from genetic 
testing for BRCA1/2 mutations, Lerman et al. (1996) found that women who received 
test results were more likely to have both health insurance and more education than those 
who refused (Lerman et al., 2002). Lower level of education is therefore considered a 
barrier to testing. This may in fact be due to the limited ability of some individuals to 
understand the information presented to them about genetic testing (Lerman et al., 1999).  
Education is also positively correlated with awareness of genetic testing (Bosompra et al., 
2001).  In addition, in a study assessing preferences for medical decision-making, 
patients who were more educated tended to take a more active role in their medical 
decisions (Arora & McHorney, 2000).   
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Age 
 Age is a known risk factor for prostate cancer and for other hereditary cancers 
(Myers et al., 2000). It has also been found to positively correlate with intention to 
undergo genetic testing. For example, in a study of at-risk relatives for colorectal cancer, 
intention to undergo testing positively correlated with increased age and perceived risk 
(Glanz et al., 1999). Although the majority of studies point to a positive correlation 
between age and intention, a study of African-American men presented with the option to 
undergo genetic testing for prostate cancer risk when it becomes available, indicated that 
age was inversely correlated with intention to undergo testing. This could potentially be 
explained by older men being more skeptical about genetic testing, by cultural factors, or 
by the fact that they believe that their current screening measures are sufficient (Myers et 
al., 2000). In addition, older patients have been found to prefer a less active role in 
medical decision-making, and they tend to prefer to leave their medical decisions to their 
physicians (Arora & McHorney, 2000). However, in a focus group investigation of men’s 
interest in prostate cancer genetic testing, age was found to positively correlate with 
interest in genetic testing (Doukas et al., 2000).  
 
Family History 
 Family history, as noted previously, is a strong predictor of prostate cancer risk. 
In fact, it appears to correlate with perceived risk as well. Known family history has also 
been found to be predictive of intention to undergo testing. For example, Lerman et al. 
(1996) found that women who were offered a genetic test for breast cancer were more 
likely to undergo testing as the number of first-degree relatives known to have breast 
    
   
25
cancer increased.  In addition, a study about attitude toward prostate cancer genetic 
testing found that family history of prostate cancer was an important factor associated 
with reported interest in testing (Cormier, Valeri, Azzouzi, Fournier, Cussenot, Berthon, 
Guillemin, & Mangin, 2002). This was also found to be true in an investigation of family 
history of prostate cancer and screening behavior, and family history also correlated with 
perceived susceptibility (Jacobsen, Lamonde, Honour, Kash, Hudson, Pow-Sang, 2004). 
Bosompra et al. (2001) also report a number of studies indicating that family history 
strongly correlates with intention to undergo genetic testing for both colon cancer risk 
and breast cancer risk.  They also report that family history is positively related to 
awareness and age.  
Relatives of colon cancer patients have often been shown to be more interested in 
genetic testing for colon cancer risk, but this has not been studied in depth (Petersen, 
Larkin, Codori, Wang, Booker, Bacon, Giardiello, & Boyd, 1999).  In fact, in their study 
of relatives of colon cancer patients, Petersen et al. (1999) found that risk perception is 
increased with number of affected relatives, but this did not directly correlate with 
increased interest in testing. However, in an investigation of factors influencing decisions 
about BRCA1/2 testing, participants who chose to undergo genetic testing were more 
likely to have a known family history as well as a desire to obtain risk information for 
their family members (Armstrong, Calzone, Stopfer, Fitzgerald, Coyne, & Weber, 2000).  
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Family Support and Social Influence 
According to the Attitude-Social Influence-Self Efficacy Model of behavior, 
social influence has a strong impact on intention to engage in a health behavior (Lechner, 
de Vries, & Offerman, 1997). “Social influence occurs in a variety of situations, 
especially where the basis for making a judgment is either ambiguous or unknown to the 
individual. In such situations the individual seeks some evidence of reality” (Olson, 
1968). Social support is defined as “any input directly provided by another person (or 
group) which moves the receiving person towards the goals which the receiver desires” 
(Baranowski, Bee, Rassin, Richardson, Brown, Guenther, & Nader, 1983).  Social 
support has long been hypothesized to influence decision-making about health behaviors. 
Although little research has been conducted related to social support or family support 
and genetic testing, it appears that both would likely influence decision-making, as they 
have in other cohorts.  
For example, in an investigation of the effectiveness of a social influence 
approach to smoking prevention, social influence was found to significantly impact 
smoking behavior (Dijkstra, Mesters, DeVries, van Breukelen, & Parcel, 1999). A study 
investigating social influence on seeking medical care for lower urinary tract symptoms 
indicates that social influence (e.g., advice from others or the media) was more important 
than symptom severity in the decision to seek medical care for their symptoms. In fact, 
advice from the social network to seek medical attention was the most influential 
predictor of actual behavior (Wolters, Wensing, van Weel, van der Wilt, & Grol, 2002).    
An investigation of breastfeeding decision-making showed that influence from 
spouses, family and doctors, did impact the decision-making process when deciding 
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whether or not to breastfeed (Baranowski, et al., 1983).  They also note that there is no 
consensus about the best approach for measuring this form of support or influence. 
Lechner et al. (1997) explained that there is evidence to suggest that direct social support 
or pressure to participate in a screening for breast cancer influences decision to undergo 
testing. They state that encouragement from spouses, friends, and physicians all influence 
intention to participate in screening. Champion (1989) investigated influences on breast 
self-exam and found that family and friends were both influential in determining BSE 
behavior.  
In the genetic testing literature, a study investigating intention to undergo genetic 
testing for colorectal cancer found that family support strongly correlated with intention 
to undergo testing (Glanz, et al., 1999).  Another study refers to the fact that 
communication and support within a family likely impact participation in both counseling 
and testing for hereditary colon cancer (Koehly, Person, Watts, Kempf, Vernon, & Gritz, 
2003). Physician recommendation has also been found to influence men’s prostate cancer 
screening behavior (Steele et al., 2000).  Lerman et al. (2002) noted that family influence 
has not been thoroughly addressed in the current literature and that it is important to view 
decision-making in the context of the family. However, they note that genetic testing for 
cancer susceptibility is partly motivated by the desire to help family members as well as 
by family support (Vernon et al., 1999, in Lerman et al., 2002; Glanz et al., 1999).  
Fear of loss of family support appears to be an important part of decision-making 
for Huntington’s disease genetic testing. General themes that emerged from a study about 
aduls’ intentions to undergo presymptomatic genetic testing for Huntington’s disease 
were potential for negative outcomes, potential benefits to the individual and to the 
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family, and fear of the loss of support from the family (Williams et al., 1999). Therefore, 
this indicates a need to address support from a family in decision-making studies.  
According to Coyne & Anderson (1999), spouses play a key role in decision-
making about genetic testing. Since genetic testing is both an individual issue and a 
family issue, many studies have focused on blood relatives. However, in a study of 
women at high risk for breast cancer who were anticipating genetic testing for breast 
cancer genes, spouses were found to be even more influential than female siblings, who 
were still influential (Coyne & Anderson, 1999).  
The typical biomedical model tends to put patients in a passive role, allowing for 
the influence of the physician to be primary. Physician influence has diminished in 
younger, more educated patients, but their influence remains strong in older, less 
educated individuals (Arora & McHorney, 2000). Thus, their suggestions are likely to be 
highly influential in patient’s decision-making about genetic testing.  
Regarding the widely debated distress after genetic testing for hereditary cancers, 
psychological impact is reportedly based more in pre-test expectations and social support. 
That is, with less support, the potential for distress after testing is higher (Marteau & 
Croyle, 1998 in Bleiker et al., 2003). In addition, Bleiker et al. (2003) suggest that social 
support is likely influential in both decision-making and in post-test adjustment.  
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Concerns about Testing 
 As with other health protective behaviors, there exist numerous barriers and 
concerns that are likely to decrease a person’s desire to engage in the behaviors.  These 
barriers tend to fall under a number of different categories. For example, with the 
potential to undergo genetic testing, many patients have concerns for their psychological 
and physical well-being (Doukas et al., 2000; Lerman et al., 2002; Coyne & Anderson, 
1999). They often have financial concerns as well as concerns related to their insurance 
status and future healthcare (Peterson, et al., 2002; Doukas et al., 2000). There are also 
concerns about family members and future children. This review will focus on a select 
few barriers that appear to be most relevant to the genetic testing literature.  
 
Insurance and Employment Concerns 
 Health insurance status has been shown to be one of the most significant barriers 
to genetic testing (Peterson et al, 2002).  In their evaluation of concerns about 
discrimination in the BRCA1 testing population, 62% of people who declined genetic 
testing endorsed items suggesting that they did so because of insurance concerns. In 
addition, there was a significant difference in decision-making based on level of income.  
There also appears to be significant risk for discrimination by health insurers 
despite the federal legislation that is currently in place to prevent the use of genetic 
information for discriminatory purposes (Lerman et al., 1996; Genome.gov, 2004).  More 
legislation is in fact underway (Genome.gov, 2004). In a number of studies, women 
offered the opportunity to undergo genetic testing for breast cancer were clearly 
influenced by health insurance status. Women without health insurance were four times 
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less likely to request testing than women with health insurance, even after controlling for 
other demographic variables (Lerman et al., 1996). Women who are less concerned about 
insurance were also found to be more inclined to undergo genetic testing for breast cancer 
susceptibility (Armstrong, Calzone, Stopfer, Fitzgerald, Coyne & Weber, 2000).  
In an observational cohort study investigating the factors that deter diagnosis of 
hereditary colon cancer, perceptions of insurance discrimination proved to be a 
significant barrier to testing for mutations. One specific participant stated that her family 
did not understand why she consented to genetic testing, and she reported that they were 
“uneducated” and that they did not follow the recommendation to undergo testing 
themselves due to fear of insurance discrimination (Lynch, Riley, Weismann, Coronel, 
Kinarsky, Lynch, Shaw, & Rubenstein, 2004).  
In their review of the motivating and deterring factors to undergo genetic testing 
for breast cancer susceptibility, Jacobsen et al. (1997) noted that along with concerns 
about test accuracy and worries about emotional responses, worry about insurability was 
one of the most commonly cited reasons to refuse testing. Similar results were found in 
the Williams et al. (1999) study of intention to undergo presymptomatic genetic testing 
for Huntington’s Disease. They reported that concern about insurance discrimination or 
fear of loss of insurance coverage were barriers to testing and were titled “potential for 
negative outcomes”. In their focus group investigation of interest in genetic testing for 
hereditary colon cancer, primary concerns were fear of loss of confidentiality, job 
discrimination, health insurance discrimination, and adverse psychological reactions. The 
authors suggest that this might motivate patients to avoid genetic testing; thereby missing 
the potential health benefits (Kinney et al., 2001).  
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 The reality of insurance discrimination is much less severe than the concerns 
expressed (Lynch et al., 2004). However, there is little data currently available to state 
this conclusively, and there could therefore be ongoing discrimination that is unaccounted 
for in the literature (Stopper, 2000). Currently, the legislation in New Jersey “prohibits 
health insurers from discriminating in the issuance, withholding, extension, renewal, or 
establishment of rates, terms or conditions on the basis of genetic information”. It 
“prohibits any person from obtaining or retaining an individual's genetic information 
without first obtaining authorization from the individual”. It also “prohibits the disclosure 
of genetic information in a manner that permits identification of the individual without 
the authorization of the individual” (Genome.gov, 2004). This appears to be fairly 
consistent across states although some states do in fact lack current updated protective 
legislation. Some states, such as Utah, also have employment discrimination laws in 
place with regard to genetic information (Genome.gov, 2004).  
 
Psychological Concerns 
In their review of the motivating factors and barriers to genetic testing for breast 
cancer susceptibility, Jacobsen et al. (1997) noted that worries about emotional responses 
were among the more common barriers to testing.  However, the majority of the literature 
about psychological aspects of genetic testing reviews the psychological impact of 
testing, rather than the anticipated emotional impact of testing considered prior to 
engaging in actual testing behavior. Available literature related to the relationship of 
concerns about potential emotional reactions and decision-making will be reviewed along 
with some of the literature about the reported psychological impact of testing.  
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In a focus group investigation, some first degree relatives of colon cancer patients 
report that they would feel less distress and worry if they were aware of their carrier 
status. Others note a concern that they will become depressed, hopeless, or anxious if 
they find out that they are a carrier and that it could reach a clinical level that would 
disrupt the quality of their lives (Kinney et al., 2001).  However, in an investigation of 
worry relative to prostate cancer genetic testing, level of worry and anxiety was low. 
Since no test was actually available, anxiety related to actual testing could not be 
measured (Cormier et al., 2002).   
 In an article reviewing multiple studies about the psychological aspects of genetic 
testing for cancer between 1992 and 2002, Bleicker et al. (2003) report that psychological 
impact depends on pretest expectations, mood, and social support (Marteau & Croyle, 
1998 in Bleicker et al., 2003).  They reported that any elevated distress is decreased after 
testing for both carriers and non-carriers. They also found that a significant amount of 
literature points to no adverse psychological consequences for patients undergoing 
genetic testing.  There is also little evidence to support any significant “survivor’s guilt” 
after testing (Cormier et al., 2003).  In an evaluation of cancer-specific distress in women 
at high risk for breast and ovarian cancer, some of the previous research is refuted in that 
distress related to genetic testing does not appear to be as high as originally thought 
(Coyne et al., 2003). They report that high risk status causes more distress than does 
genetic testing. In fact, distress associated with high-risk status or with genetic testing 
was not correlated with general psychological distress or emotional/social functioning. In 
women with higher levels of distress related to high risk status or who expected more 
distress in reaction to a positive gene test, the investigators found that they were still 
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well-adjusted. This suggests that genetic testing might provoke less distress and less of a 
need for treatment than previously thought (Coyne et al., 2003).  
In a Canadian study of psychosocial impact of genetic testing for colon cancer, a 
subgroup of individuals who had submitted to testing was found to exhibit distress, 
mostly in those waiting for results or those testing positive (Esplen, Madlensky, Butler, 
McKinnon, Bapat, Wong, Aronson, & Gallinger, 2001). Another investigation of 
correlates of distress in colorectal cancer patients undergoing genetic testing found that 
patients with less formal education and fewer social contacts were more likely to 
experience depression and anxiety related to genetic testing (Vernon, Gritz, Peterson, 
Perz, Baile, & Lynch, 1997).  
Regardless of psychological responses to genetic testing, perceptions of outcomes 
are more relevant to decision-making. In a review of psychosocial issues related to 
genetic testing for breast and ovarian cancer, Pasacreta (2003) reports that 36-80% of 
patients in various studies anticipated feeling depressed upon learning that they carried 
the mutation and 44-77% of patients anticipated feeling anxious upon learning of positive 
mutation status. It was also reported that patients anticipated a negative impact on their 
mood and increased anxiety in family members. In addition, women who anticipated a 
negative test result are reported to anticipate feelings of guilt (Pasacreta, 2003).  
According to Lerman et al. (1996), adverse psychological consequences have 
been found to result from testing in a number of studies. In addition, they report that 
women tend to anticipate an emotional impact of testing, and this likely plays a role in 
decision-making. In their investigation of determinants of Huntington’s disease genetic 
testing uptake, patients who agreed to participate in testing had fewer concerns about 
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potential emotional reactions than those who declined testing (Codori, Hanson, & Brandt, 
1994). Therefore, people with fewer concerns about potential emotional reactions tend to 
be more likely to participate in genetic testing.  
 
Health Related Quality of Life 
 The term “health” has been defined by the World Health Organization as a “state 
of complete physical, mental, and social well-being, and not merely the absence of 
disease or infirmity” (WHO, 1948 in Drotar, 1998). This definition has strongly 
influenced the definition of quality of life, which has grown to incorporate the physical, 
mental, and social dimensions noted in defining health.  It has been expanded further to 
include four primary domains: disease and physical symptoms, psychological 
functioning, functional status, and social functioning.  Health related quality of life 
(HRQL) primarily refers to the specific impact of medical treatment, health care policy, 
illness, or injury on an individual’s quality of life (Drotar, 1998; Osaba, 1994). Studies of 
health related quality of life have focused on experiences with medical care, evaluating 
usefulness of drug treatments, cost-benefit analysis of various treatments, and looking at 
the impact of an illness on a person’s life.  
 Health related quality of life can provide information about current health status 
of a patient, qualitative difference at different stages of disease, progress over time, and 
efficacy of different treatment plans (Drotar, 1998).  It can also provide an evaluation of 
current health value and status that can influence beliefs. Health is not just the ability of 
the body to function at a particular physical level. It is especially important to include 
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emotional and social dimensions when studying cancer patients because these dimensions 
are truly linked to survivorship (Jenney, Kane, & Lurie, 1995).  
 Health related quality of life is a purely subjective construct. A physician cannot 
estimate a patient’s perceived health related quality of life (Osaba, 1994).  According to 
Osaba (1994), assessing HRQL as an observer will introduce a bias by the observer’s 
own internal standard of what is a desirable health related quality of life state. However, 
assessing health related quality of life with a self-report measure provides an opportunity 
to understand an individual’s perception of their health and to begin to uncover how that 
perception influences their beliefs (Osaba, 1994). 
Results of previous studies of health related quality of life indicate that HRQL 
measurements do not always correlate with other variables in the predicted directions. 
However, recent studies addressing intention to undergo genetic testing for hereditary 
colon cancer and to learn results of tests, have found that intention is positively correlated 
with quality of life (Vernon et al., 1999). In contrast, Lewis (1997) suggests that future 
models need better accounting for results that were not expected in past research. This 
currently limits the strength of hypotheses using HRQL as a direct predictor of health 
behavior, but it appears likely that HRQL might have an indirect effect on intention to 
undergo genetic testing.  
 
Relationship of Intention to Actual Behavior 
The relationship between intention and actual behavior is becoming apparent in 
the literature. Although intent and behavior are separate constructs, they do clearly 
correlate.  Numerous studies have utilized the construct of intention as a means of 
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predicting actual behavior. In theory, intention is considered the “immediate and 
necessary precursor to behavior” (Miller, Wikoff & Hiatt, 1992; Vernon et al., 1999).  A 
study by Wulfert and Wan (1995) examines the intention to use condoms and actual 
condom use in different phases.  They found that intention is an accurate predictor of 
behavior in this particular population; that intention to use a condom (in phase one of the 
study), did in fact predict actual condom use.    
In studies specific to genetic testing for cancer, intention appears to be a good 
predictor of behavior (Vernon et al., 1999). In fact, a study evaluating intention to 
undergo genetic testing for breast cancer shows that the connection is fairly stable over 
time, and that intention may be considered a “reliable proxy” for behavior (Lerman et al., 
1996). In addition, the fact that this does not appear to change despite education and 
counseling efforts related to benefits and risks further supports the stability of the 
relationship between intention and behavior (Lerman, Biesecker, et al., 1997).  
Overall, intention to engage in healthy behaviors has been found to be one of the 
most important predictors of actual behavior, as described in the theory of reasoned 
action (Courtneya, 1994).  According to the theory of reasoned action (TRA), “a specific 
health-protective action is determined mainly by the intention to perform it” (Azjen & 
Fishbein, 1980, in Wulfert and Wan, 1995).  This theory has received a substantial 
amount of empirical support in predicting health behaviors.  Azjen and Fishbein (1975) 
proposed the TRA to explain behaviors that are under volitional control. They state that 
behavior is a function of intention, which is in turn determined by two factors, attitude 
toward the behavior, and subjective norm.  They also note that only salient beliefs need to 
be considered in this model (Cho, Keller, & Cooper, 1999).  
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DeVries and Backbier (1994) describe a model to analyze determinants of 
behavior.  They applied the Attitude-Social influence-self-Efficacy model, which posits 
that behavioral change is best predicted by a person’s intention to perform that behavior. 
This model assumes that intention is determined by the following three cognitive factors: 
attitude, social influences, and self-efficacy expectations.  This model has been 
influenced by Bandura’s Social Learning Theory, the concept of self-efficacy, and by the 
Theory of Planned Behavior (Bandura, 1986; Azjen 1991).  According to the ASE model, 
the essential way to change behavior is to study the determinants of intention to enact the 
behavior. This can help the clinician target patients in need of extra support or counseling 
(DeVries & Backbier, 1994).  
The Theory of Planned Behavior (TPB), a modified version of the Theory of 
Reasoned Action (TRA), poses that behavior is a function of salient information or 
beliefs relevant to behavior (Burks, 2001).  Intention to perform the behavior is predicted 
by attitude about performing a behavior, perceived beliefs of others regarding 
performance of the behavior, and perceived control over the ability to perform the action. 
These all affect intention, and in turn, generally predict actual behavior (Kahn, Goodwin, 
Slap, Huang, & Emans, 2001). 
 
Specific Health Beliefs and Behavioral Intent 
Beliefs are “notions that determine and shape peoples’ understanding of reality” 
(Lazarus & Folkman, 1984 in Lev, 1997).  The way people see events and appraise them 
is critical to how they both interpret and react to them. This involves judgment of whether 
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or not the event may cause harm and whether or not the situation is controllable (Lev, 
1997).   
Studies have shown that belief in efficacy of a treatment impacts intention to 
adhere to that treatment. For example, Kyngas et al. (2000) studied fifty-four adolescents 
with Juvenile Rheumatoid Arthritis. They found that the patients with greater 
understanding and belief in the efficacy of their treatment were more likely to comply.   
Miller, Wikoff, and Hiatt (1992) note that attitude and perceived beliefs have been 
found to positively correlate with intentions to comply in patients who had myocardial 
infarctions.  In addition, personal beliefs were found to correlate with intention to 
undergo Pap smears in adolescent girls and young women (Kahn, Goodman, Slap, 
Huang, & Emans, 2001).  They also report findings that 66% of the variance in behavior 
was accounted for by behavioral intention.  
Tebbi (1993) also explains that beliefs of the patient are related to enacting a 
behavior. He reports that behavior “is due, in large part, to the patient’s perceptions rather 
than the physician’s judgments of the disease and its effects” (Tebbi, 1993). Thus, belief 
is more predictive of behavior and intent to enact a behavior than other external factors.  
 
Preliminary Study 
Doukas et al. (2000) conducted twelve focus groups aimed at elucidating themes 
related to interest in genetic testing for prostate cancer in the general population. The 
study was conducted in a medium-sized United States city and incorporated 90 men from 
the general population between the ages of 18 and 70 years, and excluded men with 
current cancer or past history of cancer. Men with a family history of prostate cancer 
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were not excluded. The investigators hypothesized that men’s beliefs, attitudes, social 
influences, and demographic characteristics would be important in predicting their 
decision-making relative to genetic testing for prostate cancer. All groups were 
moderated by the same Caucasian male. The groups were divided first by ethnicity, then 
by education, and then by age. There were eight Caucasian groups, three African-
American groups, and one Asian group (which is consistent with the population in the 
study city). Prior to each group, participants viewed an educational video about the nature 
of prostate cancer genetic testing.   
After the groups were conducted, preliminary themes were mailed to all 
participants for verification. Approximately one half of the participants sent their 
feedback forms to the investigators and they provided support for the themes identified 
by the original focus groups.  The primary themes reported from this study were the 
following: beliefs about consequences, expectations, benefits for patients, beliefs about 
barriers, and susceptibility concerns.    
Beliefs about consequences encompassed thoughts about the ability to obtain 
health and life insurance, thoughts about further genetic testing that would be necessary 
in the future, fear of losing employment, stigmatization, fear of required future testing, 
concerns about how to tell the family, thoughts about prophylactic surgery, and pressure 
to receive treatment.   
Expectations encompassed practical concerns about how costs will be covered, 
lack of preventive measures available if they test positive, why to get the test if it does 
not detect current cancer, hope that genetic testing will help find a cure, and what type of 
specialist to see.  
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Benefits for patients encompassed the possibility of low cost to patients, helping 
to speed up finding a cure, peace of mind, the possibility of genetic testing being life-
saving, helping one’s family, leading to more preventive screening, helping medical 
science, and personal good.  
Beliefs about barriers incorporated fear for future insurability, cost concerns, the 
lack of curative treatment, concern about sexual function if treated, possible unnecessary 
surgery, decreased quality of life, confidentiality concerns, increases in anxiety and 
stress, and the potential to utilize genetic information for political or social gain.  
Finally, susceptibility concerns involved self-perceived risk. This perceived risk 
did appear to be related to family history of any type of cancer. African American men 
reported less enthusiasm about testing. In addition, Doukas et al. (2000) found that in this 
cohort, there was increased support for genetic testing with increased age.  
 
Summary 
The above literature review outlines some of the psychosocial factors that are 
likely to affect stated intent to engage in prostate cancer genetic testing.  In this study, we 
constructed a model with the aim of predicting intention to undergo genetic testing for 
prostate cancer based on sociodemographic characteristics, specific beliefs about benefits 
and consequences, and health related quality of life. Another focus of the model was to 
elucidate the roles of family and social influence on decision-making, as well as to clarify 
how concerns about adverse psychological and financial outcomes influence decision to 
test.   
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In conclusion, this literature review lays the foundation for incorporating not only 
age, education, income, family history, health related quality of life and beliefs about 
benefits into a model for predicting intention to undergo genetic testing for prostate 
cancer, but also two latent constructs; concern about consequuences and influence from 
family and others. In addition, the value of studying intention, in this context, is such that 
it would likely correlate with actual behavior if this was in fact a clinical trial.  
These psychosocial factors may directly affect the expression of intent, or they 
may do so indirectly. The present study expands the more common multiple regression 
model to incorporate latent constructs and mediating and moderating effects of the 
variables of interest into a structural model of stated intent. Structural Equation Modeling 
can provide a more intricate understanding of the complex relationships between the 
latent and manifest variables, while providing an opportunity to understand the direct, 
indirect, and total effects of each variable.  In general, the present study suggests a staged 
process in which the input/background demographic variables influence the processing/ 
belief variables, which in turn, directly influence intention to undergo genetic testing.    
Hypotheses derived from the literature summarized above are outlined and tested. Figure 
1 presents the basic theoretic model guiding the hypotheses.  
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Figure 1. 
Basic Theoretical Model 
BACKGROUND FACTORS (“Input”)
MEDIATING FACTORS (“Processing”)
BEHAVIORAL INTENTION (“Output”)
Intention to Undergo Genetic Testing for 
Prostate Cancer Risk 
    Age                                       Education 
    Income                                  Family History 
            Health-Related Quality of Life 
Beliefs about Benefits 
Concern about Consequences (Latent) 
Social Influence (Latent) 
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Purpose of the Present Study 
The purpose of this study was to examine the factors that influence the intention 
of men in the general public to undergo genetic testing for prostate cancer when the test 
becomes available.  More specifically, this study investigated the roles of 1) 
sociodemographic variables, 2) beliefs about benefits of testing, 3) health related quality 
of life, 4) beliefs about consequences (Concern) and 5) family and social influence 
(Commit/Influence), in decision-making about genetic testing for prostate cancer. The 
process through which such decisions are made was proposed as a staged model. The 
initial input stage incorporates the sociodemographic and background characteristics. 
These characteristics influence the processing stage which incorporates an individual’s 
belief systems, which in turn, influence test intention. 
 
Specific Aims and Hypotheses 
Figure 2 contains a structural depiction of the hypotheses. 
Aim I.   To use Structural Equation Modeling to describe the roles played by patient 
characteristics, beliefs about benefits, anticipatory concerns about consequences, 
family/social influence, on intent to undergo genetic testing as a preventive measure for 
prostate cancer.  
 Hypothesis I. Omnibus Test of the Model: It was hypothesized that the intent to 
undergo genetic testing for prostate cancer can be predicted by patient characteristics, 
assessments of specific beliefs about benefits, family and social influence, concerns about 
consequences, and health related quality of life. 
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Aim II. To identify patient characteristics and belief factors that contribute to the 
decision-making to undergo genetic testing for prostate cancer.  
Hypothesis II.a. Patient Characteristics/Demographics: It was hypothesized that 
patient characteristics such as age, income, family history, and education, would 
directly influence beliefs, and would indirectly influence test intention. That is, 
men who were older and more educated, who reported higher income, and a 
family history of prostate cancer, would be more likely to report intention to 
undergo genetic testing for prostate cancer.   
Hypothesis II.b. Health-Related Quality of Life: It was hypothesized that HRQL 
would positively influence intention to undergo testing and that this path would be 
indirect and mediated by Concern.  
Hypothesis II.c. Concern and Influence: It was hypothesized that the path from 
Influence to Concern would be significantly less than zero. That is there is a 
significant negative impact on Concern by Influence.  
Hypothesis II.d. Beliefs about Benefits: It was hypothesized that there would be a 
statistically reliable and positive path coefficient between beliefs about benefits 
and the stated intent to engage in genetic testing for prostate cancer.  That is belief 
in the benefits of genetic testing for prostate cancer risk positively and 
significantly influences test intention.  
Hypothesis II.e. Concern and Beliefs about Benefits: It was hypothesized that 
there would be a significant negative correlation between F1 (Concern) and belief 
about benefits of testing. That is, higher belief in the benefits of testing would 
predict lower concern about the consequences of testing.  
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Aim III. To elucidate the roles of family history and family/social influence played on 
men’s stated intention to undergo genetic testing for prostate cancer risk.  
Hypothesis III.a. Family History of Prostate Cancer:  It was hypothesized that 
family history of prostate cancer would directly increase intention to undergo 
testing and be mediated by both latent concerns about consequences of testing and 
by beliefs about the benefits of prostate cancer genetic screening.   
Hypothesis III.b. The Existence of a Latent Construct of Influence: It was 
hypothesized that a latent factor, “Influence” would emerge from a confirmatory 
factor analysis that ascertains the latent origin of how men’s test intention is 
influenced by the wishes of family members, friends, and professionals. It was 
hypothesized that influence of family and social network would directly correlate 
with intention to undergo genetic testing for prostate cancer risk.  
 
Aim IV. To clarify the role a latent construct of “Concern” plays on men’s intention to 
undergo genetic testing. The manifestations of Concern include stated concerns about the 
emotional consequences of testing and stated concerns about insurance and financial 
consequences of testing.  
Hypothesis IV. The Existence of a Latent Construct of Concern: It was 
hypothesized that a latent factor, “Concern” would emerge from a confirmatory 
factor analysis that ascertains the latent origin of how men’s test intention is 
influenced by their concerns about emotional and insurance/financial 
consequences of testing. It was hypothesized that Concern would negatively 
    
   
46
influence the decision to undergo testing and that it would also be moderated by 
influence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 
Hypothesized Model 
Note: Paths are labeled with their corresponding hypotheses  
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CHAPTER 3: METHODOLOGY 
 
Participants 
Inclusion/Exclusion Criteria 
Men were eligible to participate in the current investigation if they were between 
the ages of 40 and 70 years, showed no evidence of incapacity such as inability to 
understand and respond to the questionnaire, had no past personal history of prostate 
cancer, and had no current prostate cancer.  
 
Participant Recruitment 
Participants in this study included 400 healthy outpatient males between the ages 
of 40 and 70 years. They were identified with the assistance of the University of 
Pennsylvania's Office of Health Services Research for demographic characteristics of 
age, ethnicity, and absence of past or current history of prostate cancer.  Data were 
collected from May, 2001 through September, 2002. 
 A packet was mailed to potential participants including the following: 
1) a brief description of the study, 2) a written consent form to be returned by mail, and 
3) an explanation that the study would be conducted by telephone interview following 
receipt of the consent form. Potential participants were also provided with a phone 
number to call in order to decline participation or to ask questions about the consent form 
or study participation. 
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Measures 
Demographic Data 
The following information was collected by phone from patients at the time of 
participation: 1) gender, 2) date of birth, 3) race/ethnicity, 4) income, 5) highest grade 
completed, and 6) family history of prostate cancer.  See Appendix A for the related 
questions (extracted from the larger questionnaire).  
 
Beliefs and Concerns 
Prostate Cancer Genetic Screening Survey Questionnaire. A 53-item attitude 
survey was developed for this study to assess men's intention to undergo genetic 
screening for prostate cancer risk. An initial item pool of more than 100 items was 
generated from 12 focus groups consisting of  90 men from the general population 
regarding their attitudes, beliefs, and concerns about prostate cancer genetic testing 
(Doukas et al., 2000).  The item pool was ultimately reduced to 53 questions in order to 
eliminate repetitive or unclear statements. The statements were answered on a 5 point 
Likert-type scale (Strongly Disagree = 1, Disagree = 2, Neutral = 3, Agree = 4, and 
Strongly Agree = 5).  Twenty-one items were reverse-phrased to counter balance 
directionality in response scale.  Appendix B contains the belief, concern, and influence 
items included in the survey. 
 
Health Related Quality of Life 
 To measure the health-related quality of life of the respondents, the SF-12 was 
selected for its brevity. It is a twelve item self-report measure from the Medical 
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Outcomes Study and John E. Ware, and it measures health-related quality of life in two 
dimensions: psychological and physical.  The SF-12 was designed to measure general 
health status from the patient's point of view. It includes eight concepts commonly 
represented in health surveys: physical functioning, role functioning physical, bodily 
pain, general health, vitality, social functioning, role functioning emotional, and mental 
health. Results are expressed in terms of two meta-scores: the Physical Component 
Summary (PCS) and the Mental Component Summary (MCS).    
 The SF-12 was scored so that a higher score indicates better functioning. To 
calculate the PCS and MCS scores, test items were scored and normalized with a 
complex algorithm that generally requires a computer. The PCS and MCS scores have a 
range of 0 to 100 and were designed to have a mean score of 50 and a standard deviation 
of 10 in a representative sample of the US population. Thus, scores greater than 50 on 
each subscale represent above average health status. On the other hand, people with a 
score of 40, which is equal to one standard deviation below the mean score of 50, 
function at a level lower than 84% of the population, and people with a score of less than 
30, which is two standard deviations below the mean, function at a level lower than 
approximately 98% of the population (Ware, Kosinski, and Keller, 1996).    
 The SF-12 has been administered extensively for assessing health related quality 
of life across a number of populations and illnesses (Drotar, 1998; Jenney, Kane, & 
Lurie, 1995).  It has shown good reliability and validity (.67 for PCS-12 and .97 for 
MCS-12). Studies of the SF-12 indicate that on the PCS factor, test-retest reliability was 
.89 and on the MCS was .76 (Ware et al., 1996).  This test can be administered in 
approximately two minutes (Ware et al., 1996).   
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Intention to Undergo Testing   
 There is no validated formal measure of genetic testing intention for this specific 
population. A number of studies (e.g., McCaul, Sandgren, O’Neill, & Hinsz, 1993; Freed, 
Ellen, Irwin, & Millstein, 1998; and DeVries & Backbier, 1994) used just one Likert-type 
question to assess intention. For example, “how likely is it that you will return for your 
follow-up appointment?” was used as the only assessment of intent (Freed et al., 1998).  
McCaul et al. (1993) used the statement, “I intend to conduct breast self-examination at 
least once each month over the next six months.” In both studies, patients responded on a 
7-point Likert scale ranging from 1 = extremely unlikely to 7 = extremely likely.  
 Rodgers and Brawley (1993) used two single 7-point Likert-type questions to 
assess behavioral intention for exercise and eating. They included: 1) “intention to try to 
adopt healthier eating habits over the next four weeks” and 2) “ intention to participate in 
physical activity about two times per week over the next four weeks.” The first question 
assesses for desired intention and the second assesses for the self-prediction type of 
intention.   
 Participants in this investigation were asked to respond to statements, embedded 
in the larger questionnaire, about willingness to undergo testing using a five point Likert-
type scale (from 1= Strongly Disagree to 5 = Strongly Agree) modeled after the studies 
cited above.  The primary intent statement was, “I would want the genetic test for 
prostate cancer risk when it becomes available”.  For verification purposes, the 
remaining five intent statements were retained due to the fact that the targeted outcome 
variable turned out to be too homogeneous, with the majority of respondents expressing 
positive intent.  See Appendix C for the intent statements.  
    
   
51
Procedure 
 A recruitment packet, including an informed consent form, was first mailed to the  
prospective participants. Participants were told that their participation was completely 
voluntary and that they could withdraw from the study at any time.  Instructions in the 
packet also explained the goals of the study. At the beginning of the telephone interview, 
participants also gave oral consent. Participants did not receive remuneration for their 
participation in this study. 
 
Telephone Interview 
 The survey was conducted using Computer-Assisted Telephone Interviewing 
software (MacCATI, Scenecio Software) to reduce error and missed responses. Prior to 
data collection, in-person interviews were conducted by trained interviewers in order to 
pilot test the telephone survey. This pilot testing included randomly selected men, 
between the ages of 40 and 70, in a primary care office, in order to verify the clarity of 
the survey's content and format.  The actual script and questionnaire are available upon 
request. 
The present study was approved by the Institutional Review Boards of the 
University of Pennsylvania and Drexel University.  
 
Data Analyses 
Data analyses were completed using SAS version 8.02 for PC.  
Sample size plays a significant role in the estimation and interpretation of the 
results of Structural Equation Modeling. Critical sample size for maximum likelihood 
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estimation has been estimated to be 200, with above 500 being “too sensitive” thereby 
detecting too many differences (Hair, Anderson, Tatham, & Black, 1995). The bare 
minimum recommended is ten observations for each estimated parameter. In the 
hypothesized model, that would require a minimum of 140 observations (Schumacker & 
Lomax, 1996). This study incorporates the responses of 400 men, and is therefore 
sufficient to detect model fit without becoming “too sensitive”. Cohen (1977) noted the 
importance of effect size since lower numbers decrease the power of the statistics. 
According Schumacker & Lomax (1996), for a small to medium effect size,  a sample 
size of 400 will achieve a high degree of statistical (≈.80) power in order to produce a 
small to medium effect size with a p=.05 (type I error) for Structural Equation Modeling.   
 
Descriptive and Exploratory Analyses 
Descriptive analyses and exploratory analyses were performed before testing 
specific hypotheses.  These descriptive statistics were used to determine the 
appropriateness of the proposed hypothesis tests.  They included data visualization, 
frequency counts, tests for normality, correlations, and tests for multicollinearity.  For the 
independent and dependent variables, the means, medians, and standard deviations were 
calculated.  These tests were performed to explore the trend in the data, and to 
supplement the factor-analytic and path models described below. Statistical significance 
of hypothesis tests is generally reported using a type I error rate of 0.05.  Actual p-values 
were provided whenever possible.   
Following the descriptive and exploratory analyses, factor analysis preceded the 
construction of a conceptual SEM model.  Highly correlated subscales were hypothesized 
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to share a common latent origin and were thus likely manifested by a latent 
construct. Two latent constructs were hypothesized in this model. Using SAS PROC 
CALIS, a confirmatory factor analysis was run, followed by Structural Equation 
Modeling/Covariance Structure Analysis to test the hypothesized model.  Maximum 
likelihood parameter estimation with an iterative, Newton-Raphson optimization 
technique was used to estimate all models in order to account for non-normality and non-
linear effects (Hatcher, 2003).  Due to the fact that there is not one single statistic thought 
to be the best measure of overall model fit, various fit statistics were calculated.  
This was followed by modifications of the model such as adding or removing 
paths, in order to improve the overall model fit. In addition, reduced models were 
constructed to test specific hypotheses after the final model was defined. Hypotheses 
were either tested by evaluating the significance and magnitude of path coefficients or by 
model comparisons using fit statistics.  
 
Hypothesis I 
Hypothesis I /omnibus test of the model, required an overall test for the validity of 
the model using the proposed variables to predict the intent to engage in genetic testing 
for prostate cancer risk.  Specifically, the omnibus test of the model was carried out by a 
Chi-square test. Other statistics such as GFI, NFI, AGFI, PGFI, PNFI, AIC, and RMSEA 
were also carried out.  
The Chi-square statistic compares the model’s predictions with the observed data. 
A larger Chi-square indicates a larger difference between the predictions and the 
observed data. Therefore, a smaller Chi-square indicates a better model fit. The Goodness 
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of Fit Index (GFI) ranges between 0 and 1.0 (perfect fit). GFI is the percent of observed 
covariances explained by the covariances implied in the model. It is independent of 
sample size and robust against non-normality.  The Normed Fit Index (NFI) reflects the 
proportion by which the researcher’s model improves fit compared to a null model fitted 
by random variables. The Adjusted Goodness-of-Fit Index (AGFI) is a variant of the GFI 
that makes adjustments for degrees of freedom and is associated with models with almost 
perfect fit. The PGFI and PNFI test the parsimony or simplicity of the GFI and NFI, by 
adjusting for degrees of freedom. They are primarily used to make comparisons between 
models. The Akaike Information Criterion (AIC) adjusts the model Chi-square to 
penalize model complexity. An AIC close to zero reflects good fit (Schumacker & 
Lomax, 1996). The RMSEA Root Mean Square Error of Association is the average 
difference per degree of freedom expected to occur in the population, as opposed to in the 
sample. It evaluates approximate rather than exact fit of the model and it attempts to 
correct for the tendency of the Chi-square statistic to reject any model with a large 
enough sample (Hair et al., 1995). Values less than .08 are acceptable.  In general, we 
expected the p values of the fit indices to be near 1.0, meaning that the model’s 
predictions were nearly indistinguishable from men’s actual intent to undergo prostate 
cancer genetic testing.  See Appendix D for a table of Goodness of Fit Indices and 
relevant values.  
A representation of the hypothesized structural equation model can be found in 
Figure 2. This figure structurally depicts the overall hypothesized model as well as the 
hypotheses in Aims II through IV. This model is referred to as the Hypothesized Model.  
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Hypothesis II 
To test Hypothesis II.a./patient characteristics/demographics, the statistical 
significance of the respective path coefficients for age, income, education, and family 
history were evaluated.  Hypothesis II.b./health related quality of life, was tested by 
evaluating the significance of the direct path from HRQL to Intent as well as the path to 
Concern. Hypotheses II.c./Concern and Influence, II.d./beliefs about benefits, and 
II.e./Concern and beliefs about benefits, were tested in the same manner.  
 
Hypothesis III 
Hypothesis III.a./family history of prostate cancer, was tested by evaluating the 
statistical significance of several path coefficients. The hypothesis would be supported if 
the direct path between family history and intent results in a statistically significant path 
coefficient.  Moreover, the mediating effect of concern and benefits represented in the 
diagram as the connection from family history to concern or to benefits and then to intent 
would also be associated with statistically significant path coefficients.   
  Hypothesis III.b./the existence of a latent construct of Influence, was tested by 
constructing a reduced model without the latent construct of influence and the associated 
manifest variables and paths. The direct path leading from Commitment/Influence to 
intent was therefore eliminated in the reduced model.   This reduced model was 
compared with the final model with respect to all test statistics outlined above (Chi-
square, GFI, CFI, NFI, PGFI, PNFI, AIC, and RMSEA).  
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Hypothesis IV 
 Hypothesis IV./the existence of a latent construct of Concern, was tested by 
model comparisons as well as by the statistical significance of several path coefficients. 
A reduced model was constructed without the latent construct of Concern and the 
associated manifest variables. The direct paths from influence to Concern and from 
Concern to intent were thus eliminated from this model.  
 
Model Reduction Method  
Theoretical as well as statistical criteria were used to evaluate the simplification 
of the full model in Figure 2 into reduced, more parsimonious alternative models.  When 
a variable or a latent construct was considered for elimination, its theoretical merits and 
statistical properties were considered simultaneously.  Theoretical merits often took 
precedence because, in part, there is no single goodness of fit statistic that dominates all 
others.   
In general, if the removal of a variable or a latent construct substantially altered 
all test statistics, then the variable was flagged for further evaluation.  A variable was not 
considered a good candidate for removal if the reduced model showed: 1) only a 
statistically significantly reduced Chi-square, suggesting improved fit of the model, but 
no substantial increase in NFI, GFI, AIC, AGFI, or other adjusted fit indexes that favored 
model simplicity, 2) that converging evidence in the literature had strongly indicated the 
importance of the variable or latent construct, and 3) a sacrifice of variables that were 
theoretically or conceptually fundamental in the present study.  Criterion 3) involved the 
investigators’ subjective judgments, an important part of model selection considered by 
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other authors as well (Kaplan, 2000). Thus, both theoretical and statistical considerations 
guided the decision-making process for modification of the model.   
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CHAPTER 4: RESULTS 
 
Participants 
The 400 men who participated in this investigation represented an overall 
response rate of 48.1%.  Of the 1685 eligible potential participants, 844 could not be 
approached due to disconnected phones, lack of response/no answer, death, etc. Of the 
remaining 831 men identified as potential participants, 431 refused to participate either 
by phone prior to the interview or at the time of the interview. Table 1 summarizes the 
demographic characteristics of the 400 participants. 
 Respondents were fairly evenly divided between the age decades. The mean age 
was 56 years (SD=8.44, range=41 to 70).  Participants were primarily Caucasian (72%) 
and African American (22%).  The remaining 6% included 1% Hispanic, 2% Asian, and 
3% other. This is roughly reflective of the population in the Greater Philadelphia 
Metropolitan Area, which is composed of approximately 75% Caucasian, 20% African 
American, 5% Hispanic and 5% Asian.  The majority of respondents had completed 
either high school (37%) or college (35%); 22% had not completed high school and 6% 
had a postgraduate degree. Mean years of education was 16.03 (SD=3.27, range=5 to 24). 
Seventeen men (4%) reported less than $15,000 annual household family income, 74 
(19%)  fell between $15,000 and $45,000, 84 (22%) reported income between $45,000 
and $75,000, 90 men (23%)  fell between $75,000 and $105,000, 107 (28%)  men 
reported income over $105,000, and 15 men (4%) refused to report their income. In 
addition, 82.2% of the men in this study reported no family history of prostate cancer and 
17.8% reported a family history of prostate cancer.  
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  Table 1.  Demographic Characteristics  
 
Variable N % 
Age 
     40-59 
     50-59 
     60-69 
 
133 
143 
124 
 
33 
36 
31 
Ethnicity 
     Caucasian 
     African American 
     Hispanic  
     Asian  
     Other 
 
288 
87 
5 
8 
10 
 
72 
22 
1 
2 
3 
Education 
     < High School 
     High School Graduate/Some College  
     College Graduate 
     Post-Graduate Degree 
 
86 
149 
141 
23 
 
22 
37 
35 
6 
Family Income 
     $15,000 or less 
     $15,001 – $45,000 
     $45,000 – $75,000 
     $75,000 - $105,000 
     More than $105,000 
     No response 
 
17 
74 
84 
90 
107 
15 
 
4 
19 
22 
23 
28 
4 
 
 
Preliminary Analyses 
Prior to formal data analysis, all reverse scored items were recoded. Screening of 
the data included replacing missing values on the items of the scales with the means or a 
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linear estimation with nearby points. All correlation coefficients for exogenous variables 
were <.80, therefore, there was no evidence of multicollinearity in this dataset.  All 
findings were based on the self-report of participants. 
The SF-12 was scored using the published scoring algorithms from the SF-12 
manual and run through the SAS statistical package. The SF-12 (HRQL) total mean score 
was 105.08 (SD=10.53), the Physical Component Summary score had a mean of 50.48 
(SD=8.89), and the Mental Component Summary score had a mean of 54.60 (SD=6.89). 
This suggests that the average HRQL for men in the present investigation is slightly 
higher than that of the norm, although by less than one standard deviation. The four 
questions in the phone survey that assessed belief in benefits had a total possible score of 
20, with higher scores indicating greater belief in benefits of testing. The mean score for 
benefits was 14.65 (SD=1.94). Psychological consequences were assessed by five 
questions, with a total possible score of 25. Higher scores equal more anticipated 
psychological consequences. The mean score for Psychological consequences was 11.83 
(SD=3.00).  Insurance and employment consequences are measured by three questions 
with a total possible score of 15. In this analysis, the mean score was 7.52 (SD=2.50).  
For the commitment to decision/propensity to resist influence of others scale, 
higher scores indicate greater commitment to one’s decision/less influenced by others. 
One relevant concern about this measure is that it assumes a tendency toward intention to 
test.  For Spouse influence, one question was utilized, with a mean of 3.76 (SD=.93).  For 
Family influence, two questions were utilized, with a mean of 7.63 (SD=1.75). Finally, 
Other influence is measured by three questions with a mean of 9.60 (SD=2.69). 
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Questions/statements used to assess benefits, concerns, and Commitment/Influence can 
be found in Appendix B. 
Intention was measured by six statements with a possible total score of 30. For 
this scale, higher scores indicate greater intention to test. The mean score was 24.4 
(SD=3.6). This scale was negatively skewed (skewness=-1.19), indicating that the 
majority of men would state intention to undergo testing if the test were available. The 
maximum likelihood estimation technique utilized in this investigation appears to be 
robust to this normality violation therefore no transformation was employed (Schumacker 
& Marcoulides, 1998).  The actual intent statements used in the phone survey can be 
found in Appendix C.  See Table 2 for a summary of means and standard deviations for 
the SF-12 belief measures, and intention. 
 
 
Table 2. Means and Standard Deviations of the SF-12 (PCS, MCS), Benefits, Concern, 
Commitment/Influence, and Intention (N = 400) 
 
Scale Mean Standard 
Deviation 
Range (min/max) 
SF-12 a 
TOTAL 
      PCSb 
      MCSc 
 
 
105.08 
50.48 
54.60 
 
10.53 
8.89 
6.89 
 
68.3(49.0/117.3) 
46.6(18.7/65.2) 
45.4(21.0/66.5) 
 
BENEFITS (4 questions) 14.65 1.94 12.0 (8.0/20.0) 
CONCERN  
     Psychological (5 questions) 
     Insurance (3 questions) 
 
11.83 
7.52 
 
3.00 
2.50 
 
16.0 (5.0/21.0) 
12.0 (3.0/15.0) 
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Table 2. Continued 
 
Scale Mean Standard 
Deviation 
Range (min/max) 
COMMITMENT/INFLUENCE 
     Spouse (1 question) 
     Family (2 questions) 
     Other   (3 questions) 
 
3.76 
7.63 
9.60 
 
.93 
1.75 
2.69 
 
4.0 (1.0/5.0) 
8.0 (2.0/10.0) 
12.0(3.0/15.0) 
INTENTION 24.36 3.60 21.0(9.0/30.0) 
a Higher scores are associated with better functioning; bPhysical Component Score;  cMental Component 
Score 
 
 
 
Confirmatory Factor Analysis 
Correlation and Internal Consistency 
All items assumed to be influenced by the two hypothesized latent constructs in 
this study were subjected to both correlation and reliability analyses.  
Items hypothesized to be influenced by Concern, and to make up the 
psychological and insurance consequence scales, had a moderately high internal 
consistency as measured by a standardized Cronbach alpha of .70 (α = .70). This is 
considered high enough to support the use of these questions to measure beliefs in 
consequences on the two scales (Hatcher, 2003; Hair et al., 1995). All items related to 
insurance concerns were highly correlated with one another. The highest correlation was 
between concerns about health insurance and concerns about life insurance (r = .59). 
Correlations between health insurance concerns and employment concerns (r = .22) and 
between health insurance and employment concerns (r = .27) were also highly 
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significant, although slightly lower.  The individual items comprising psychological 
concerns also primarily highly correlated among themselves. For example, concerns 
about anxiety and about the future were very highly correlated (r = .49), as were guilt and 
thoughts about ending life (r = .49). The correlation between anxiety and feeling bad 
about oneself was similarly high (r = .45). In addition, the two scales, psychological 
concerns and insurance concerns were significantly correlated (r =.35, p<.0000). This 
provides support for the existence of the hypothesized latent construct (Hypothesis IV). 
See Table 3 for the correlation matrix for these items.    
  
Table 3.  Correlation Matrix for Individual Items Related to the Composite Scores for 
Psychological and Insurance Concerns and the Latent Construct Concern (F1) 
 
Note: all values are significant at p <.01 or better; 
a   Items comprise Psychological Consequences: Endli = will want to end life, Guilt = will feel guilty, Feel 
= will feel worse about self, Anx = will feel anxious, Futur = will be concerned about future;  
b  Items comprise Insurance Consequences: Health = concern about health insurance, Life = concern about 
life insurance, Job = concern about employment. See Appendix B for specific questions.  
 
Items hypothesized to be influenced by social network were found to have high 
internal consistency, as measured by a standardized Cronbach alpha of .86. The highest 
   
Psychological Concerns  
 
Insurance Concerns 
 
 Indicator ENDLI GUILT FEEL ANX FUTUR HEALT LIFE JOB 
 ENDLI a         
Psychological GUILT a 0.49        
Concerns FEEL a 0.26 0.25       
 ANX a 0.16 -- 0.45      
 FUTURa -- -- 0.28 0.49     
Insurance HEALTb 0.18 -- 0.17 0.22 0.18    
Concerns LIFE b 0.13 -- 0.27 0.30 0.21 0.59   
 JOB b 0.32 0.25 0.22 -- -- 0.22 0.27  
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correlations were between wife and children (r =.71) and relatives and friends (r =.75). 
All items were highly correlated, thereby providing support for the use of the identified 
questions to construct the scales related to the hypothesized latent construct Influence 
(Hypothesis III.b.). See Table 4 for the correlation matrix for these items. 
 
 
Table 4. Correlation Matrix for Individual Items related to the Composite Scores for 
Spouse, Family, and Other Influence and the Latent Construct Commitment/Influence 
(F2)a 
 
Note: all correlations are significant at p <.0001; a Raw alpha coefficient for Commitment/Influence is α= 
.85, and standardized alpha coefficient is α=.86; b Spouseinf: Wife= if wife says no.; c  Familyinf: Child =  
if children say no, Rel = if other relatives say no; d  Comprises Otherinf: Friend = if friends say no, MD = if 
my doctor says no, Special = if specialist says no. See Appendix B for specific questions.  
 
 
 
In addition, the three scales comprised of these items, spouse influence, family 
influence, and other influence, were highly correlated with one another, as originally 
predicted.  Correlations were: spouse influence and family influence (r =.71); spouse 
influence and other influence (r =.55); and family influence and other influence (r =.70). 
The standardized Cronbach alpha of .85 provides further support for the existence of a 
latent construct that influences responses to these scales thereby providing support for 
Hypothesis IV.    
The initial plan was to label the construct “Influence”, implying that it measures 
an underlying propensity to be influenced by people in the social network.  Upon 
Indicator WIFE CHILD REL FRIEND MD SPECIAL 
WIFE b       
CHILD c 0.71      
REL c 0.58 0.64       
FRIENDd 0.48 0.55 0.75          
MD d 0.45 0.46 0.39   0 .34         
SPECIAL d 0.38 0.44 0.42   0.36 0.60        
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examination of the questions during analysis, it became evident that the questions were 
framed so that they more likely measured a person’s propensity to reject the influence of 
social network and remain committed to test intention (see Appendix B). Thus, the 
construct might consist of both commitment to intention to test, and the tendency to reject 
the influence of others. The construct was therefore relabeled “Commitment/Influence” 
in order to better represent what is being measured.  
 
Construct Validity of Concern and Commitment/Influence Measures 
 To evaluate construct validity, the items selected to make up the Concern and 
Commitment/Influence factors were submitted to a factor analysis. Confirmatory factor 
analysis was performed utilizing the Proc Calis procedure with the 400 participants in the 
subject pool. Construct validity of the factor structure was evaluated by the indicator 
reliability, which is known to be comparable to the R2 statistic (Hatcher, 2003). 
Standardized factor loadings were also used to show the commonalities between the 
latent variables and their observable manifest variables.  
As predicted by the preliminary analyses, all factor loadings were highly 
significant (p<.001). The factor loading for psychological concern was .95 and the factor 
loading for insurance concern was .37, meeting minimally acceptable criteria for this 
sample size, thereby supporting the existence of the latent construct Concern (Hypothesis 
IV) (Hair et al., 1995). The lower loading for insurance concerns suggests that there is a 
higher commonality between the latent construct and psychological concerns than that 
between the latent construct and insurance concerns.  Thus this implies that men surveyed 
are somewhat more motivated by concerns about psychological consequences of testing 
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than by insurance and financial concerns. The factor loading for spouse influence is .75, 
for family influence is .95, and for other influence is .74. These factor loadings are all 
moderately high to high, thereby suggesting the existence of a latent construct 
Commitment/Influence and providing support for Hypothesis III.b.   
The reliability of the loadings (R2) are: psychological concerns (.89), insurance 
concerns (.14), spouse influence (.56), family influence (.90), and other influence (.54). 
This once again points to the relative strength of psychological concerns over insurance 
concerns. The composite reliability for Concern is .58, and the Cronbach’s alpha, as 
reported above, was .70. These reliability estimates are thought to be analogous, but there 
exists some debate about which index should be reported in CFA.  Since the items in the 
scale are moderately highly correlated with one another, this composite reliability score is 
similarly moderate.  The composite reliability for Commitment/Influence is .80, and 
Cronbach’s alpha is .86. Both indicate highly correlated items, and fairly high 
reliability/internal consistency of the scale. Table 5 displays standardized factor loadings, 
t values, and reliabilities for the confirmatory factor analysis model.  
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Table 5. Standardized Factor Loadings, t Values, and Reliabilities for the CFA Model 
 
 
 
 
 
 
 
                                                     
 
 
 
 
 
Note: all loadings are significant at p <.001; a Composite Reliability;  
b Raw/standardized alpha coefficient for Concern (F1) is α= .70 (above minimally acceptable); 
c Raw alpha coefficient for Commitment/Influence (F2) is α= .85; standardized alpha coefficient  is α=.86 
 
 
 
 The relative fit of the CFA model is described by the fit statistics.  The chi square 
(χ2) was nonsignificant, indicating that this proposed model’s predictions are not 
significantly different from the observed data, which provides support for this model. In 
addition, the Goodness of Fit Index (GFI) was very high (.99), Adjusted Goodness of Fit 
Index (AGFI) which penalizes for model complexity, was also very high (.98).  The 
Comparative Fit Index (CFI), which is compared to a null model, was also extremely 
high (.99). Table 6 provides the fit indices for this model. These indices suggest a very 
good fit for this model, thus supporting the existence of the two hypothesized latent 
constructs, and the lack of a significant relationship between them.  
 
 
 
Indicator Standardized 
Factor 
Loading  
t value Indicator Reliability (R2) 
Concern (F1)      0.58a,b     
Psyconc 0.94 25.11 0.89 
Insconc 0.37 7.33 0.14 
Commit/Influence 
(F2) 
     0 .80a,c    
Spouse 0.75 16.29 0.56 
Family 0.95 22.08 0.90 
Other 0.74 16.00 0.54 
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Table 6. Fit Statistics for the Confirmatory Factor Analysis Model 
 
Goodness of Fit Measures Original Model  
Chi Square (χ2)a 10.29 (DF=6), p=.1134b 
 
Goodness of Fit Index (GFI) .99 
Root Mean Square Error of Approximation 
(RMSEA) 
.04 
Adjusted Goodness of Fit Index (AGFI) .98 
Comparative Fit Index (CFI) .99 
Normed Fit Index (NFI) .98 
Akaike Information Criterion (AIC) -1.72 
Parsimonious Normed Fit Index (PNFI) .59 
Parsimonious Goodness of Fit Index (PGFI) .59 
Note:  DF= degrees of freedom; bNon-significant χ2 reflects good model fit, χ2ratio to DF is 1.72, 
 reflecting good fit since the ratio is <2.0.  
 
 
 
Figure 3 provides a structural depiction of the CFA model showing factor 
loadings. Error terms are as follows: Spouse (e1) = .66, Family (e2) = .31, Other (e3) = 
.68, Psychological Concerns (e4) = .33, and Insurance Concerns (e5) = .93. The 
particularly high error for Insurance concerns is noteworthy.  The -.16 covariance 
between Commitment/Influence and Concern indicates that individuals with more 
concern are somewhat less likely to be committed to their intention to undergo testing. 
One standard deviation increase in Commitment would occur with a .16 standard 
deviation decrease in Concern and vice versa. The CFA model indicates that the selected 
indicators appear to measure what they were expected to measure. 
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Structural Equation Model 
Original Model 
Figure 2 provides a summary of the initial structural equation model (SEM) with 
paths labeled for each hypothesis used for the analysis. Overall fit statistics guide the 
researcher’s decision-making about whether or not to accept the model or to make further 
modifications.  We expected to see a relatively good overall model fit based on the fit 
statistics. That is, we expected to see most fit statistics meeting at least minimum criteria 
Figure 3. 
Confirmatory Factor Analysis Model 
KEY 
***  p <.001 
**  p <.01 
 
COMMIT 
F2 
SPOUSE 
FAMILY 
OTHER  
.75***
.95***
.74***
INS CONC 
PSY CONC 
CONCERN
F1 
.94***
.37***
e1 
e2 
e4
e3 
e5
-.16**
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for adequate fit. For example, we expected to see a nonsignificant chi-square, a CFI, GFI, 
AGFI, and NFI greater than .90, the RMSEA less than .08, and an AIC close to zero.  
 For the initial model, evaluation of the chi-square and comparative fit index 
(CFI), suggested that minimal support could be found for the hypothesized model, χ2 
(127, DF = 37), p < 0.0001. The Comparative Fit Index met minimum criteria for 
acceptance of the model (CFI = .91). The Goodness of Fit Index (GFI) was adequate 
(GFI =.95), but the Adjusted Goodness of Fit Index (AGFI) was not high enough to 
support this model (AGFI= .88).  The RMSEA estimate, which should be less than .08, 
was .09, which further provides support for model modification. Akaike’s Information 
Criterion (AIC), for which acceptable values are closer to zero, was 53.97, indicating a 
significant discrepancy between the hypothesized model and the actual data. Therefore, 
the overall model does not provide an adequate fit for the data, and the initial hypothesis 
testing the proposed model should be rejected. See Table 7 for fit statistics for this model.  
 
Model Modifications  
Post-hoc model modifications were performed on the initial model in an attempt 
to develop a better fitting, more parsimonious model. It is important to note that structural 
equation modeling should be theory driven, and modifications should be made with 
theoretical grounding, since data-driven modifications alone can threaten the validity of 
the model. All modifications in the present investigation were driven by theory and 
supported by data. 
Upon examination of the fit indices and theoretical relevance, two prediction 
paths were added between the “processing/belief” variables.   First, a prediction path was 
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added between Belief in Benefits and F1/Concern. It was expected that a person’s beliefs 
in the benefits might be attenuated by their concerns about the consequences of testing.  
This path was found to be statistically significant in the final model (t =2.4, p<.05) and to 
improve the fit of the model. It implies that a person’s beliefs in the benefits of testing 
(inversely) influence their concern about consequences and provides support for 
Hypothesis II.e. These two variables were also found to significantly covary (.39, p<.01), 
as was predicted in the original model.   
A prediction path was added between the latent factor of F2/ 
Commitment/Influence and the manifest variable belief in benefits. This was guided by 
the theoretical change in the meaning of this construct, thereby leading the investigator to 
hypothesize that the tendency to remain committed to test intention is more likely to 
influence the positive belief variables and perhaps indirectly influence concerns. 
Therefore, the path from Commitment/Influence to Concern was also dropped 
(Hypothesis II.c. and Hypothesis IV). This added path was found to be statistically 
significant (t=7.54, p<.001). This implies that commitment to one’s intention despite 
influence of others predicts a person’s beliefs in the benefits of testing. Revision 1 was 
submitted to another analysis through Proc Calis. The χ2 difference test was conducted in 
order to determine whether this version of the model was a significantly better fit of the 
data. The difference was significant at the .001 level. Thus the fit of the obtained data, χ2 
(80.14, DF= 38), p < .001; CFI = .96; GFI = .96; and AGFI = .92 was significantly 
improved. See Table 7 for fit indices for Revision 1.  
Upon examination of the fit indices, path coefficients, and theoretical relevance, a 
prediction path between age and health related quality of life was dropped, since it was 
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consistently nonsignificant in two previous submissions of the data. A covariance path 
was added between health related quality of life and income (.20, p >.001), due to 
theoretical relevance and examination of the correlations and covariances in the prior data 
submission. Finally, family history, which was dichotomous and strongly skewed toward 
“no family history of prostate cancer” (skewness = -1.69; 82.2% no history, 17.8% yes 
history), was dropped from the analysis for this reason and for the lack of significance of 
any of the three paths in the prior data submissions. Thus, Hypothesis III.a. was not 
supported. Implications of dropping family history from the analysis will be discussed.  
Revision 2 was submitted to another analysis through Proc Calis. Based on the χ2 
difference test (significant at .01), this revision significantly improved the fit of the 
obtained data χ2 (58.92, DF = 29), p = .0008; CFI = .98; GFI = .96; and AGFI = .92 over 
revision 2. See Table 7 for fit indices for Revision 2.  
 
Final Model 
Upon examination of the fit indices, significance of selected paths, and theoretical 
relevance, the path from HRQL to intention was dropped from the analysis, providing 
support for Hypothesis II.b. It was initially entered into the model with the expectation 
that it would be disconfirmed and the expectation that the path from HRQL to F1 would 
be more meaningful in the model. In addition, paths from age and education to 
Commitment/Influence were added. Those paths were removed from benefits to avoid 
redundancy. The final SEM model was submitted to an analysis through the Proc Calis 
procedure.  This data submission further improved the fit of the obtained data and the 
final model achieved a χ2 (51.71, DF=31, ratio= 1.67), p = 0.01. Although this value is 
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significant, it is less so than previous submissions. In addition, Hatcher (2003) suggests 
that if the ratio of chi square to degrees of freedom is less than two, it should be 
considered supportive of the model. The Comparative Fit Index, which compares the 
model against a null model, displayed excellent model fit (CFI = .98), as did the 
Goodness of Fit Index, which compares the model’s predictions against the observed data 
(GFI = .97). The Adjusted Goodness of Fit Index was also adequate (AGFI = .94). The 
Root Means Square Error Estimation was excellent (RMSEA=.04), as was the Normed 
Fit Index (NFI = .95), which indicates more covariance accounted for with higher scores. 
The χ2 difference test was conducted between revision 2 and this model which was 
significant at .05 and between the original and final models which was significant at .001. 
Given these statistics, this was determined to be the final model for this investigation. 
Table 7 provides a summary of fit indices for the models tested, and displays the 
improvement in model fit as the revisions progressed.  
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Table 7. Fit Statistics for Original, Revised, and Final Model 
 
Goodness of Fit 
Measures 
Original 
Model  
Revision 1 Revision 2 Final Model 
Chi Square (χ2)a 127.97 
(DF=37), 
p<0.0001b 
80.14 
(DF=38), 
p<0.0001 b  
58.92 
(DF=29) 
p=0.0008 b 
51.71 
(DF=31), 
p=0.01c 
 
Goodness of Fit 
Index (GFI) 
0.95 0.96 0.97 0.97 
Root Mean Square 
Error of 
Approximation 
(RMSEA) 
0.09 0.06 0.06 0.04 
Adjusted Goodness 
of Fit Index (AGFI) 
0.88 0.92 0.93 0.94 
Comparative Fit 
Index (CFI) 
0.91 0.96 0.97 0.98 
Normed Fit Index 
(NFI) 
0.88 0.92 0.94 0.95 
 
Akaike Information 
Criterion (AIC) 
53.97 4.14 0.93 -10.29 
Parsimonious 
Normed Fit Index 
(PNFI) 
0.50 0.53 0.50 0.54 
Parsimonious 
Goodness of Fit 
Index (PGFI) 
0.53 0.55 0.51 0.55 
a DF= degrees of freedom; bVery highly significant χ2 reflects poor model fit;  cSignificant χ2 reflects poor 
fit, but χ2ratio to DF is 1.67, which is < 2.0 and considered acceptable, particularly given the strength of 
other fit statistics for the Final Model.  
 
For the final model, the standardized path coefficients are provided in Table 8. 
The path from Age to F2 is significant and the standardized coefficient is .15, indicating 
that older persons are likely to be more committed to their decisions/more resistant to 
influence from others. The path from age to F1 did not achieve significance, but since it 
was close to a significant t-value (1.70), it was retained in the model. The standardized 
path coefficient was -.11.  The path from education to F2 was significant (-.12). This 
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indicates that men with lower education are more likely to remain committed to their 
decision.   The path from income to F1 was significant and negative (p<.05, -.14), 
indicating that lower income contributes to more concern about consequences. HRQL 
displays a significant negative path to F1 (p<.01, -.20), indicating that poorer HRQL 
predicts more concern about consequences. Belief in benefits displays a significant 
negative relationship with F1 (p<.05, -.39) and a highly significant positive path to 
intention (p<.001, .35), supporting the notion that greater belief in benefits predicts less 
concern about consequences and greater intention to test. F2 displays a highly significant 
path coefficient (p<.001) to both belief in benefits (.38) and intention to test (.52). The 
path from F1 to intention is significant (p<.05, -.11) and is negative, indicating that more 
concern about consequences decreases intention to undergo testing.   
 
Table 8. Standardized Path Estimates for the Final Structural Model  
 
*** significant at p <.001, **significant at p <.01, *significant at p<.05, none – not significant; 
- no direct path  
 
 
 
 The standardized coefficients/factor loadings for the two factors in the final 
model can be found in Table 9. All paths were highly significant and positive (p<.001). 
The path from F1 to Psyconc was .81 and to Insconc was .46, supporting the existence of 
  Endogenous 
 
Exogenous 
Commit/Influence
F2 
Concern 
F1 
Benefits Intention 
Age   .15** -.11 - - 
Education           -.12* - - - 
Income -   -.14* - - 
HRQL -    - .20** - - 
Benefits -   -.39* -      .35***    
F2 - - .38***      .52*** 
F1 - - - -.11* 
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a shared latent origin and suggesting a stronger impact on psychological concerns. The 
path from F2 to Spousinf was .81, to Familyinf was .93, and to Otherinf was .76, 
supporting the existence of a shared latent origin. These results are consistent with the 
confirmatory factor analysis.  
 
Table 9.  Standardized Factor Loadings for the Final Structural Model  
 
 
 
 
 
 
 
Note: all listed values are significant at p <.001; -- no direct path 
 
 
The direct, indirect, and total effects in the final model can be found in Table 10. 
In addition to the direct effects reported in the tables, the indirect impact of a number of 
variables is notable. Of particular interest are the effects on the primary dependent 
variable, intention. For example, although there are no direct connections between the 
‘background/input’ variables and intention, they do influence intention in an indirect 
manner. Level of education (-.14), age (.11), income (.02), and HRQL (.02) exert a small 
influence on intention to undergo testing that is filtered by the ‘belief/processing’ 
variables. The total effect of belief in benefits on intention (.39) is influenced by the 
direct impact of F2 (.37) on benefits, and the indirect effects Age (.06), and Education 
 (-.04) on benefits as well as the influence felt through F1 (.04). This is a highly 
significant impact, and belief in benefits appears to be central to the current model.  Of 
particular interest is the impact of F2 on Intention. The direct effect (.52, p<.001), in 
Endogenous 
 
Exogenous 
Spouseinf Familyinf Otherinf Psyconc Insconc 
F2   .81 .93 .76 -- -- 
F1 -- -- -- .81 .46 
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combination with the effect felt through benefits and F1 (.15), suggests a total impact of 
.67, thereby clearly exerting the most influence on intention in this model.  
Therefore, Table 10 shows that the greatest influence on intention is exerted by 
the belief variables, and their influence appears to be influenced/moderated by the 
background characteristics.  
 
Table 10.  Direct, Indirect, and Total Effects of Variables in the Final Model  
Dependent Variables 
                         By Variable 
Direct Indirect Total 
Effects on F2 
                    Education
Age 
 
-.12 
.15 
 
-- 
-- 
 
-.12 
.15 
Effects on F1 
                     Age
                    Income
HRQL
Education
F2
Benefits
 
 
-.11 
-.14 
-.20 
-- 
-- 
-.39 
 
-.02 
-- 
-- 
.02 
-.14 
-- 
 
-.13 
-.14 
-.20 
.02 
-.14 
-.39 
Effects on Benefits 
                      Age
                    Education
F2
 
-- 
-- 
.37 
 
.06 
-.04 
-- 
 
.06 
-.04 
.37 
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Table 10. Continued 
 
Dependent Variables 
                         By Variable 
Direct Indirect Total 
Effects on Intention 
Education
Age
Income
HRQL
F2
F1
Benefits
     
 
-- 
-- 
-- 
-- 
.52 
-.11 
.35 
 
-.14 
.11 
.02 
.02 
.15 
-- 
.04 
 
-.14 
.11 
.02 
.02 
.67 
-.11 
.39 
     Note: --  no direct path 
 
 
 
Figure 4 presents the final SEM model obtained from the data with the significant 
coefficients presented in standardized form. Error terms are as follows: Benefits (e6) 
=.92, Psyconc (e7) = .59, Insconc (e8) = .89, Spouse (e9) = .59, Family (e10) = .36, Other 
(e11) = .65, and Intent (e12) = .66.  The errors in general indicate what has not been 
explained by the model.  The relatively high measurement errors for Benefits and 
insurance concerns show that a good amount of variability in men’s beliefs in the benefits 
of genetic testing and their concerns about losing insurance remain unexplained.  
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KEY 
  * p < .05 
** p < .01 
*** p < .001 
     Figure 4. 
      Final Model 
INS CONC
PSY CONC
SPOUSE 
FAMILY 
OTHER  
AGEEDUC 
INTENT
 
COMMIT
F2 
 
CONCERN 
F1 
 
BENEFITS 
INCOME HRQL 
e6
d1
.52***
.35***  -.11*
-.39*
.39**
.38*** .20*** 
  .81*** 
  .93*** 
  .76*** 
.81*** 
.46***
-.12*
.15**
-.11 -.14*
-.20**
.37***
e7
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e11
e1
e9
e10
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Model Reduction/Hypothesis Testing 
 Two hypotheses required further testing to determine the importance of their 
contribution to the final model. The existence of the latent construct, 
Commitment/Influence is proposed in Hypothesis III.b., and the existence of a latent 
construct Concern is proposed in Hypothesis IV. Both were tested in the confirmatory 
factor analysis and results are reported above. However, their relevance to the model was 
tested by constructing two reduced models, removing the latent constructs, their 
indicators, and all associated links, in order to determine if they should be retained in the 
model.   
 Based on the χ2 difference test, which did not achieve significance, and on the 
observation of the fit statistics, the removal of Concern did not significantly improve the 
overall fit of the obtained data, χ2 (32.18, DF= 18), p =.02; CFI = 0.98; GFI = .98; 
RMSEA = .05; and AGFI = .95.  There were slight improvements in these statistics, but 
none were substantial. In addition, the parsimonious fit indices provided less support than 
those in the final model (PGFI =.49, PNFI = .48). This supports retaining Concern in the 
final model. Table 11 provides a summary of fit indices for the final model and the two 
reduced models. 
 The removal of Commitment/Influence from the final model improved the overall 
fit of the obtained data, χ2 (10.22, DF= 10), p =.42; CFI = 1.0; GFI = .99; RMSEA = .01; 
and AGFI = .97.  There were slight improvements in these statistics, but the only 
substantial improvement over the final model was the chi square statistic, which became 
nonsignificant. In addition, the χ2 difference test was significant at the .05 level. The 
improvement in the CFI, which increased by .03, was also notable. The parsimonious fit 
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indices were significantly worse in this reduced model (PGFI = .36 and the PNFI = .35), 
which provides support for retaining Commitment/Influence in the final model.  
Although there is some indication that removing Commitment/Influence from the model 
slightly improves overall fit, this is partially due to change in model complexity. There 
does not appear to be substantial evidence for dropping it from the model, and doing so 
would decrease complexity and theoretical richness of the model, so 
Commitment/Influence was retained in the final model. Table 11 provides a comparative 
summary of fit statistics. 
 
Table 11. Fit Statistics for the Reduced Models 
 
Goodness of Fit 
Measures 
Final Model Minus F1 
(Concern) 
Minus F2 
(Commitment) 
Chi Square (χ2)a 51.71(DF=31) 
p=.01b 
 
32.18 (DF=18) 
p=.02 b 
10.22 (DF=10) 
p=.42 
Goodness of Fit Index 
(GFI) 
.97 .98 .99 
Root Mean Square Error 
of Approximation 
(RMSEA) 
.04 .05 .01 
Adjusted Goodness of Fit 
Index (AGFI) 
.94 .95 .97 
Comparative Fit Index 
(CFI) 
.98 .98 1.0 
Normed Fit Index  
(NFI) 
.95 .96 .97 
Akaike Information 
Criterion (AIC) 
-10.29 -3.72 -9.78 
Parsimonious Normed Fit 
Index (PNFI) 
.54 .48 .35 
Parsimonious Goodness 
of Fit Index (PGFI) 
.55 .49 .36 
a DF= degrees of freedom; bSignificant χ2 reflects poor fit, but χ2ratio to DF is < 2.0 and considered 
acceptable, particularly given the strength of other fit statistics. 
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Combined with theoretical considerations, the above findings generally provide support 
for the “final model” over the other models tested. The final model was therefore 
retained.  
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CHAPTER 5: DISCUSSION 
 
The purpose of the present study was to use Structural Equation Modeling to 
investigate the roles played by patient characteristics, health related quality of life, beliefs 
about benefits, concerns about consequences, and family/social influences on intention to 
undergo genetic testing as a preventive measure for prostate cancer. This study proposed 
that men’s stated intention to undergo genetic testing for prostate cancer would be 
primarily distally related to sociodemographic characteristics and proximally related to 
beliefs, concerns, and influence. The overall predictions were generally supported by the 
analysis. However, a number of hypotheses were not fully supported, and one factor was 
not adequately labeled.  
As predicted, the final model in this investigation suggests that demographic 
characteristics and health related quality of life are not directly predictive of intention to 
undergo testing. It suggests that they comprise the “input” that influences the beliefs that 
go into making a decision. These characteristics are necessary temporal precursors, and 
could not be predicted by the belief variables. The “processing” portion of the model 
incorporates commitment to one’s decision/influence from social network, beliefs in 
benefits and concern about consequences. Commitment is the least studied of these 
variables and it has been found to exert the greatest influence in this model. However, all 
of these three factors were found to be directly predictive of intention to undergo genetic 
testing for prostate cancer, as was predicted in the original model.   A more specific 
breakdown of the final model follows.  
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Demographic Variables/Distal Influences 
 As suggested in the health belief model literature, level of education, level of 
income, and age, were all found to influence the “processing” variables as hypothesized 
(van der Pligt, 1996; Goldring et al., 2002). The hypothesis suggesting that reported 
family history of prostate cancer would influence beliefs and concerns was not supported, 
and family history was removed from the model. In addition, health related quality of life 
was hypothesized to be significantly correlated with Concern. This hypothesis was also 
supported by the model. 
 
Level of Education 
Level of education appears to moderate the impact of Commitment/Influence on 
the belief in benefits of testing. In the present study, it negatively influences belief in 
benefits after being mediated by Commitment/Influence. That is, more educated 
individuals tend to be less committed to their intention to undergo testing and to believe 
less in the benefits of testing. Education does not appear to significantly impact concern 
about consequences, which is somewhat counterintuitive. It would appear that the 
“demographic” characteristics should affect both belief-related constructs, but in the 
current investigation the impact of education appears to be absorbed by (the more 
positive) Commitment and belief in the benefits of testing. Although it is possible that 
this will be found in other investigations, this result could be specific to this particular 
sample or to the construction of the model. Based on the results of this investigation, 
level of education does not directly impact intention; its effect is filtered through the three 
‘processing’ variables in this model as originally predicted.    
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 However, Edwards et al. (2002) suggested that for African American men, this 
relationship would be positive, and in the present study, it was found to be negative. 
Other studies have suggested positive correlations and have indicated that low level of 
education is often seen as a barrier to testing in a variety of cohorts (Bosompra et al., 
2001; Lerman et al., 1996). For example, in a study related to genetic testing for 
hereditary colon cancer genes, persons with more education and history of past utilization 
of genetic testing were more likely to undergo testing (Lerman et al., 1999). This was 
consistent with findings in the literature about genetic testing for breast cancer as well 
(Lerman et al., 2002).   
 Therefore, the present finding that men with lower levels of education are more 
likely to state their intention to test for prostate cancer, as evidenced by the total effect of 
education on intention, is inconsistent with the current literature. The current finding 
might be specific to prostate cancer genetic testing, as opposed to other cancer cohorts. 
This finding might also be explained by the possibility that men with more education 
might be more willing to consider the opinions of others and that they might be less likely 
to believe in the benefits of testing without obtaining more information.  Similarly, it is 
possible that less educated men are less aware of the potential for negative outcomes and 
potentially inconclusive test results. Based on this investigation, there is reason to further 
investigate the role played by level of education on influencing decision-related beliefs.   
 
Income 
Consistent with the predictions, findings from this study suggest that although 
level of income does not directly impact stated intention to undergo testing for prostate 
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cancer genes, it significantly impacts level of concern, which in turn, directly influences 
test intention.  Men with lower income tend to report more concerns and are therefore 
less likely to state that they intend to undergo testing. Men with higher reported income 
are less likely to express concerns about consequences of testing. This is suggested in the 
literature, in that people who have more financial freedom often have fewer fears about 
insurance payments and employment (Peterson et al., 2002; Weinrich et al., 2000). It 
appears likely that higher income predicts higher intent to undergo genetic testing 
because individuals with higher income are likely to have more access to healthcare and 
more security with regard to coverage of costs.  Other studies have suggested that higher 
income or socioeconomic status predicts greater uptake of genetic testing for cancer 
genes. For example, patients who were offered genetic testing for colon cancer 
susceptibility were found to utilize testing more if their income/SES was higher. Thus, 
there appeared to be a positive correlation between SES and test uptake (Lerman et al., 
1999).  
Income is likely more strongly linked to decreased insurance and employment 
concerns than to psychological concerns. In a study investigating barriers to genetic 
testing for breast cancer, Peterson et al. (2002) found that lower income participants were 
more concerned about insurance coverage and were therefore less inclined to engage in 
testing.   In addition, lower income men have been found to engage in less prostate cancer 
screening behavior than men with higher income. Weinrich et al. (2000) found that even 
if screening is free, lower income men tend to be afraid of the results and the ultimate 
financial burden posed by the findings. 
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It is also possible that concerns about psychological consequences are diminished 
by the freedom to seek treatment and by the increased ability to pay. Men with greater 
financial stability might also feel that they are less vulnerable to such consequences.  The 
concept of low income as a barrier to testing continues to be supported by this model.  
 
Age 
Results of the present study suggest that age is inversely correlated with concern 
about consequences of testing. Thus younger individuals are slightly more likely to be 
concerned about consequences of testing and are therefore somewhat less likely to 
undergo testing, barring the influence of the other variables in the model. Age positively 
influenced Commitment, and indirectly belief in benefits, so it appears that older 
individuals remain more committed to their decisions and are not only less likely to be 
influenced by their social network, but they are also more likely to believe in the benefits 
of testing. Some of the current literature suggests otherwise.  For example, Myers et al. 
(2000) reported that older African American men tend to be less inclined to undergo 
testing and are often more skeptical about genetic testing, and that they tend to believe 
that their current screening measures are sufficient.  This particular finding might be 
accounted for by cultural influences. 
However, the majority of the literature is consistent with the findings in this study 
which suggest that increased age is predictive of greater intention to test (Glanz et al., 
1999). Additionally, in the preliminary focus group investigation of men’s interest in 
prostate cancer genetic testing, age was found to positively correlate with interest in 
genetic testing (Doukas et al., 2000). In addition, in a study of relatives at risk for 
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colorectal cancer, intention to undergo testing positively correlated with increased age 
and perceived risk (Glanz et al., 1999). 
The finding that younger individuals might be less likely to undergo testing 
because of more concerns about consequences could be due to the fact that younger 
individuals expect that they have more years left to live, and that they have legitimate 
worries about their employment and insurance status and benefits to their families. Older 
men might believe that those benefits will either not be affected, or that those changes 
will not significantly impact their well-being. They might be less concerned about caring 
for their families, because, perhaps their children are older and more independent. 
Younger individuals might be more concerned about the influence on their job status as 
well as on their emotional well- being, given the likelihood of a having a younger family 
requiring more financial and emotional support.   
 
Health Related Quality of Life 
            Although hypotheses incorporating perceived health related quality of life are 
often not supported, those incorporated in this investigation were in fact supported by the 
data in the present study. As predicted, HRQL was not found to strongly and directly 
impact intention to undergo testing. HRQL indirectly influenced intent as evidenced by 
its significant negative influence on level of Concern which in turn, impacts intent. In this 
investigation, men who perceived themselves to have a lower HRQL had greater 
concerns about the consequences of testing and were less likely to state that they intend 
to engage in testing, and men who perceived themselves to be healthier expressed fewer 
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concerns. The impact of health-related quality of life on intention to undergo testing is 
therefore mediated by concern about consequences.  
Men who perceive themselves to be healthier, are not necessarily objectively 
healthier than men who report a lower HRQL since the SF-12 is not an objective measure 
of health status, rather it is a self-reported perception of such status. Men who believe 
that they are healthier, in this case, express fewer concerns about consequences of testing. 
This could be explained in a number of ways. For example, a man who perceives that he 
is healthier might think that he is less likely to test positive for a prostate cancer gene and 
therefore be less concerned about the consequences of testing. Or, the observed 
covariance between income and health related quality of life might indicate that men with 
higher HRQL might have more access to healthcare or might feel similarly invincible to 
the potential consequences of treatment. A man who reports lower health related quality 
of life might fear learning more “bad news” about his health. He might also feel that his 
health could be further compromised and then become concerned about the psychological 
impact as well as the potential for health insurance or employment difficulties.   There are 
a number of explanations for the impact of HRQL on concern about consequences, but it 
is important to take into account that past studies have not consistently found that HRQL 
plays a role in the decision-making process. Findings from this study, however, suggest 
that a continued focus on the indirect impact of HRQL on intention will likely be more 
informative.  
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Family History 
It was hypothesized that family history of prostate cancer would both directly 
correlate with intention to undergo testing and be mediated by both Concern and belief 
about benefits. In the present study, family history of prostate cancer does not 
significantly impact intention to undergo testing.  The family history variable was 
removed from the present model due to its lack of significance, but it continues to be 
theoretically relevant to the decision-making process, due to the fact that it is so closely 
tied to risk, and it should be considered for future investigations.  
In the present study, men were not selected on the basis of family history, and a 
very small percentage of participants in this study acknowledged having a family member 
diagnosed with prostate cancer, so its influence was difficult to detect. In addition, the 
extent of family history was not assessed in this investigation. When men are identified 
as ‘high risk’ for the purpose of participating in genetic testing protocols, a history of one 
family member with a prostate cancer history will not be considered adequate, 
particularly if it is not a first-degree relative such as a brother, father, or son. 
In general, in order to identify men as ‘high risk’, they must be part of families 
with apparent ‘hereditary prostate cancer’.  In such families, the inheritance pattern 
appears similar to a dominant trait. It is comprised of a group of three or more first-
degree relatives with prostate cancer, as well as prostate cancer in each of three 
generations in either maternal or paternal relatives; or two or more first or second-degree 
relatives with prostate cancer under the age of fifty-five years (Kupelian et al., 1997; 
Nieder et al., 2003). Increased risk can also be seen with even one or two relatives 
diagnosed with prostate cancer. This is often referred to as ‘familial prostate cancer’ but 
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this group is not considered a primary target for genetic testing (Nieder et al, 2003; 
Kupelian et al., 1997). 
 In this investigation, men either endorsed ‘yes’ or ‘no’ for family history without 
noting which relative was diagnosed, the number of relatives affected, or their age at 
diagnosis, so the utility of this question is unclear. However, men who selected ‘yes’ for  
family history appear to be somewhat more likely to be concerned about the 
consequences of testing, and men with more concerns about consequences are less likely 
to be inclined to undergo testing. This slight trend appears to contradict the current 
literature, which strongly suggests that family history predicts increased participation in 
genetic testing (Bosompra et al., 2001; Jacobsen et al., 2004, Lerman et al., 1996; 
Cormier et al., 2003). However, given that they have some degree of family history, it is 
possible that those men have more realistic concerns about psychological consequences 
and insurance/employment consequences than men without a family history. Given the 
higher risk for prostate cancer among African American men, it would be helpful to 
include ethnicity in the model since there is a greater reason to target a group that might 
require greater intervention in order to improve early detection.  
Past studies strongly suggest that family history both directly and indirectly 
positively correlates with intention to undergo genetic testing. Results of a study about 
attitudes toward prostate cancer genetic testing suggested that family history of prostate 
cancer was an important factor associated with reported interest in testing (Cormier et al., 
2002). This was also found in an investigation of family history of prostate cancer and 
screening behavior, and family history also correlated with perceived susceptibility 
(Jacobsen et al., 2004). Bosompra et al. (2001) also report a number of studies indicating 
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that family history strongly correlates with intention to undergo genetic testing for both 
colon cancer risk and breast cancer risk. Thus, there remain compelling reasons to 
incorporate family history in future models, particularly since the current result appears 
to be unique to this sample.  
 
Processing Variables/Proximal Influences 
The belief and processing constructs were all found to directly influence intention 
to undergo testing for prostate cancer genes. Belief in the benefits of testing was found to 
be a strong predictor of intention to test, as was commitment to one’s beliefs/tendency to 
reject the influence of others. The notion of men’s commitment to their test intention is 
one of the least studied of the processing variables. It was notable that this was the 
strongest predictor of test intention in the present model, indicating that men’s 
determination to remain committed to their intention to undergo testing outweighed the 
influence coming from other sources.  Concern about consequences exerted the least 
influence but its impact was still significant and negative, as predicted. A more detailed 
discussion follows.  
 
Belief in Benefits  
Results of this investigation suggest that belief in the benefits of testing is a strong 
predictor of intention to undergo genetic testing in this population, as hypothesized. This 
is also consistent with the genetic testing literature and the health belief model literature. 
For example, in their investigation of intention to undergo genetic testing for cancer in 
the general population, Bosompra et al. (2000) found that perceived benefits were 
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proximally predictive of intention to undergo genetic testing for cancer (Bosompra et al., 
2000). In addition, in a study investigating intention to undergo genetic testing for breast 
cancer genes, Martinez (2002) found that intention to undergo testing increased with 
higher number of perceived benefits of testing for BRCA1/2 mutations in Hispanic 
women. 
In the current model, belief in the benefits of testing is influenced by a person’s 
tendency to remain committed to their decisions despite social influence and it is not 
strongly and directly influenced by any other variables. Belief in benefits displays both a 
strong direct effect on intention and an indirect impact that is mediated by level of 
concern about consequences of testing.  The relationship between belief in benefits and 
concern about consequences is strong and negative, as expected. When a person has a 
stronger belief in benefits of testing, they are very likely to have fewer concerns about the 
consequences of genetic testing. Although the effect of belief in benefits on intention to 
test is mediated by level of concern about consequences, belief in benefits appears to be 
more influential in the decision-making process than does concern about consequences. It 
appears that a decisional- balance or utility approach to studying decision-making would 
enhance this investigation by helping to develop a decision-making tool for men who are 
deciding whether or not to undergo testing.    
 
Concern about Consequences 
The underlying propensity to be concerned about consequences of testing was 
supported by the factor analysis in this model. As hypothesized, men’s concerns about 
the psychological impact and insurance/employment impact were found to be correlated 
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and to significantly negatively influence intention to undergo testing. This indicates that, 
barring the influence of belief in benefits and commitment to one’s intentions, the more 
concerns an individual experiences, the less likely he is to state intention to undergo 
testing.  
Psychological concerns were more strongly correlated with the underlying factor 
Concern, than were insurance and employment concerns. This was evident in the 
preliminary analyses, because most men did not express a high level of concern about 
insurance and employment consequences in this sample. This could, however, be related 
to the generally high income reported by men in this particular sample, since men with 
higher income are less likely to have reason to worry about insurance-related 
consequences of testing. It also remains possible that men are genuinely more concerned 
about the emotional consequences of testing than they are about insurance and 
employment consequences. These results are consistent with those of other studies. For 
example, similar results were seen in the Armstrong et al. (2000) study in which women 
who were less concerned about insurance were found to be more inclined to undergo 
genetic testing for breast cancer susceptibility. Similarly, Jacobsen et al. (1997) noted that 
along with concerns about test accuracy and worries about emotional responses, worry 
about insurability was one of the most commonly cited reasons to refuse testing. 
The health belief model posits that perceived consequences of testing would 
inversely correlate with intention to perform a health behavior (van der Pligt, 1996).     
Consistent with theory and with predictions in this investigation, the higher the level of 
concern about consequences, the less likely men were to state their intention to engage in 
testing.  Concern also appears to be a “gateway” for a number of the demographic 
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variables in this investigation. Age, health related quality of life, and income, all 
influence intention indirectly after being mediated by level of Concern.  Concern does 
appear to be a central factor in this model, acting as a filter for the effects of the 
demographic variables mentioned above. This provides support for the notion that the 
belief and concern factors act as processing modules through which decisions are made.  
 
Commitment/Influence 
The originally hypothesized factor labeled “Influence” was marginally supported 
in the present study, because the questions intended for use in the confirmatory analysis 
do not appear to clearly measure this particular construct. The questions appear to 
combine both influence and a person’s commitment to their decision. Therefore, 
influence is only marginally assessed in this study. The construct actually measured 
appears to be a combination of these two constructs, and although it can be considered a 
‘rejection of influence’ variable, it has been given the name “Commitment/Influence”. 
The higher men score on Commitment/Influence, the less likely they are to be influenced 
by family and other members of social network and the more committed they appear to 
be to test intention. A clearer measure of the construct of influence will be of particular 
interest in future studies.  
The latent factor Commitment/Influence, propensity to remain committed to one’s 
intention and to resist the influence of spouse, family, and others, was strongly supported 
by the confirmatory factor analysis, as was reported in Chapter 4. Commitment/Influence 
was then found to have a highly significant impact on intention as predicted, as well as a 
significant impact on belief in benefits. The more committed they were to their intention 
    
   
96
to test, the more strongly men in this study tended to believe in the benefits of testing. 
Commitment/Influence also indirectly and negatively influenced concern about 
consequences, thereby providing support for the hypothesis that F2 would influence 
Concern. Thus, if men expressed a higher level of commitment to test intention, they 
tended to express lower levels of concerns about consequences of testing. Commitment is 
influenced by age and level of education, with a stronger positive influence by age. That 
is, one’s commitment to their intention and tendency to resist the influence of other tends 
to increase with age and decrease with level of education.  
It is notable that men appear to be determined to remain committed to obtaining 
information about susceptibility to prostate cancer and that this intention appears to 
outweigh the influence of  opinions expressed by family members, physicians, and other 
members of the social network. This conceivably relates to a belief that results only affect 
the individual. It is also possible, given the very personal nature of prostate cancer and 
the relationship of its treatment to sexual functioning, that men feel a need to guard their 
privacy and to protect their self-esteem by engaging in testing regardless of other 
influences.   
 
Intention 
As previously noted, it has been found that interest in genetic testing for cancer 
risk is relatively high, ranging from 45% to more than 90%, depending on the targeted 
population (Jacobsen et al., 1997; Vernon et al., 1999; Bowen et al., 1999). Results of this 
investigation were consistent with these estimates, in that 83.25% of men expressed an 
interest in testing. That is, 46.25% stated that they intended to get tested and 37% stated 
    
   
97
that they would probably get tested. This is encouraging and useful information to present 
to physicians, genetic counselors, and medical ethicists, whose goal it will be to inform 
men about the testing process so that they may maximize prevention efforts by increasing 
screening behaviors, and eventually by using preventative treatments.  
The majority of men who participated in this study stated that they would submit 
to testing when it becomes available. Although it is likely that the interest in genetic 
testing for prostate cancer is genuinely high and is likely encouraging to geneticists, there 
are a number of potential explanations for this response pattern that are not based purely 
on actual test intention. First, the use of a phone survey with no accountability for their 
responses such as setting a date for testing, taking the test immediately, or going for a 
pretest visit, allows participants to state that they would take the test without concern 
about following through. This is particularly true since the test does not yet exist.    
Second, there if often a tendency toward a social desirability response bias, which 
in this case would likely lead to an overestimation of test intention. This bias was not 
assessed in the present investigation. This could be assessed in future investigations using 
the Marlowe-Crowne Social Desirability Scale (Crowne & Marlowe, 1960). However, 
despite this potential bias, as noted in Chapter 2, stated intention to test appears to be a 
good predictor of behavior (Vernon et al., 1999). In a study evaluating intention to 
undergo genetic testing for breast cancer, the connection is fairly stable over time, and it 
appears that intention may be considered a “reliable proxy” for behavior (Lerman et al., 
1996). In addition, the notion that this does not change due to education and counseling 
about benefits and risks further supports the stability of this relationship (Lerman, 
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Biesecker, et al., 1997). Therefore, stated intention can generally be accepted as 
representative of test behavior. 
Third, the participants in this investigation were not known to be ill or at higher 
risk for prostate cancer than the general population. Thus, this topic is not likely to be as 
central to the men in this study. Men with a strong family history, which was not assessed 
in this study, are commonly targeted separately as a “high risk group” and their responses 
could potentially differ from those of the men in this study. Based on the results of the 
current study, the strength of family history was not assessed, so the finding that men 
with a family history are slightly but not significantly more likely to be more concerned 
about consequences of testing is unlikely to be meaningful in this particular investigation. 
However, many studies have shown that family history strongly correlates with intention 
to undergo testing (Lerman et al., 1996; Armstrong et al., 2000). Men with a strong 
family history are also likely to have greater beliefs in the benefits of testing, which tends 
to overpower Concern in the current model (Armstrong et al., 2000).  
Future studies would offer a better explanation of the results if a more focused, 
high risk population was targeted. This would be helpful since genetic testing for cancer 
genes is currently only offered in research protocols to high risk patients, it is not 
currently available for prostate cancer, and it is unlikely to be implemented population-
wide in the near future (Collins, Green, Guttmacher, & Guyer, 2003; Lerman & Shields, 
2004).  
Taken together, these findings suggest complex interrelationships between 
sociodemographic variables, beliefs, concerns, and health related quality of life in the 
context of decision-making for genetic testing for prostate cancer. These results did not 
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differ dramatically from past studies involving women testing for breast cancer genes or 
from women and men testing for colon cancer genes.  The findings are also primarily 
consistent with those of investigations using structural equation modeling and similar 
constructs to predict intention to undergo genetic testing for cancer in numerous cohorts 
(Bosompra et al, 2000; Bosompra et. al, 2001; Bunn et al., 2002).  Results of this 
investigation suggest that younger men with less education, higher income, fewer beliefs 
in the benefits of testing, lower health related quality of life, who tend to be less 
committed to their decisions, and who express greater concern about potential 
consequences of testing, would be the least likely to state their intention to undergo 
genetic testing for prostate cancer. These men would also be the primary targets for 
counseling and educational intervention. Although family history was not significant in 
this model, it remains both practically and theoretically relevant to genetic testing, since 
testing protocols target men from high risk families.  
 
Limitations  
The following section reviews some of the limitations of this investigation. Many 
of the limitations of the present study have already been addressed throughout this 
chapter, but will be reviewed here in more detail. 
 First, although Structural Equation Modeling (SEM) is a sophisticated statistical 
procedure through which intercorrelations and interdependence relationships can be 
assessed, there are a number of limitations inherent to its use.  Selection effects can be 
felt through biased selection of indicators for each factor. In the present study, indicators 
were carefully selected, but there remains a possibility that other indicators might have 
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enhanced measurement of the factors.  Generalizability is also uncertain for 
investigations utilizing SEM methodology (MacCallum & Austin, 2000). For example, 
the current model assessed the influence of beliefs of men in a generally healthy 
outpatient male population. Generalizing these results to an identified high risk 
population is therefore not recommended.  In addition, the present sample appears to be 
biased toward higher income men. This does not appear to be reflective of the general 
population and is likely due to sampling bias. Men who were recruited for this study had 
regularly presented at a major medical center for outpatient visits and had responded to 
mailed recruitment packets. It is possible that higher income men were more accessible 
and displayed a higher response rate, thereby further limiting the generalizability of the 
findings in this study.    
Another limitation to the use of SEM is the potential for a confirmation bias. 
Since there is an inherent susceptibility to favor the model being evaluated over other 
explanations of the data in SEM, it is therefore important to consider that other 
explanations of the data are likely to exist (MacCallum & Austin, 2000).  In the current 
investigation, a model generation approach, which combines the confirmatory approach 
and the alternative models approach, was employed, and there exists some concern about 
loss of validity due to data driven modifications. In this case, modifications were 
considered from a theoretical perspective prior to actual incorporation into the analysis.  
It is important to remember that no true model exists and that all models are incorrect to 
some degree (MacCallum & Austin, 2000).  Thus, results of this investigation, as with 
models tested in other investigations, essentially suggest that the final model provides 
only a plausible explanation of the data.   
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 A second limitation in the present study is the limited number of questions used to 
assess each indicator in the model. In addition, the lack of validated measures could be 
construed as a limitation although this is not uncommon in such exploratory 
investigations (the decision-related, practical aspects of genetic testing for prostate cancer 
have only begun to be explored, as the specific genetic tests are just beginning to 
emerge).  The only validated measure included in this model was used for the 
measurement of health-related quality of life. All other questions were based on a focus-
group investigation conducted in the preliminary study (Doukas et al., 2000).  Questions 
were categorized by theme and were confirmed by a mailed-in post-focus group 
questionnaire. Future investigations might include validated measures for each construct.  
Another potential limitation of this study is the measurement and distribution of 
primary dependent variable. Intent is the only dependent variable used in this study and 
there exists no standardized measure for this construct that would be applicable for this 
particular study. Many past studies have utilized one to five questions to assess for intent. 
This study incorporated one primary and five backup questions to measure intention. In 
this case, the responses to the primary intent statement were skewed toward stating 
positive intention to test. As explained above, there are numerous possible explanations 
for this distribution of responses. After careful consideration, the primary intent statement 
was combined with five backup intent questions for this investigation, but this frequency 
distribution was skewed toward positive intent as well, although somewhat less so. The 
skewed frequency distribution potentially influenced the results of this study toward the 
“positive” predictors of undergoing testing, and it is possible that with more evenly 
distributed responses, the strength of belief in benefits might decrease and that of 
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Concern might increase. This is not likely a significant concern because the maximum 
likelihood estimation technique used in the analysis was likely robust against this 
distribution (Schumacker & Marcoulides, 1998). In addition, the majority of the literature 
continues to point to the stronger influence of benefits over negative aspects of testing.  
 Although the initial plan in this investigation was to measure the influence of 
family and social network on decision-making, it became clear that this measure was not 
purely assessing influence. Social influence, as explained by Deutsch and Gerrard (1955), 
typically involves going along with other’s requests despite private disagreement. This 
investigation appears to assess the rejection of such influence.  The variable in this study, 
as noted previously, appears to measure commitment to one’s decision to test and 
rejection of social influence. This is a limitation to this investigation, as adequate 
measurement of influence was assumed. Future investigations should incorporate a more 
clearly defined measure of influence in order to more clearly understand its role in 
complex decision-making process.  
Another minor limitation of this investigation is the study of income rather than 
socioeconomic status. Although the difference is unlikely to be substantial, it appears 
relevant to note that socioeconomic status is not formally measured in this study. Future 
studies could be enhanced by incorporating a standardized measure of socioeconomic 
status. Socioeconomic status can be determined using the Four-Factor Index of Social 
Status (Hollingshead, 1975), which is composed of an index of social position including 
occupation, education, marital status, and sex.  Raw scores range from 8 to 66, and 
subjects are placed in one of five possible social class levels, with Class I representing the 
lowest social position, and Class V representing the highest social position. 
    
   
103
As noted above, one possible confound in assessing intention to undergo testing 
was likely the effect of social desirability bias. According to Crowne & Marlowe (1960), 
social desirability is defined as the need for persons to obtain approval by responding in a 
culturally acceptable manner. It manifests itself in the tendency of people to overestimate 
their actual behavior relating to its socially desirable aspects (Latif, 1998). People are 
often tempted to provide a socially desirable response rather than to state what they really 
think or do. This is often seen as a function of the general need for approval and the 
specific demands of a situation (Nancarrow & Brace, 2000).  
It appears likely that, if a person is asked if they are willing to, or if they are 
planning to engage in a recommended health behavior, they will respond more positively 
if they have higher social desirability scores. This can constitute a threat to predictive 
validity and it can contaminate the independent variables in an investigation (O’Brien, 
1989).   In survey and self-report research such as the present study, social desirability 
can be a cause for spurious (e.g., false) effects. Social desirability can also help determine 
whether the independent variable shares variance with the social desirability instead of 
with the dependent variable. 
It is possible that social desirability bias might partially explain a discrepancy 
between stated intention and actual test uptake as well. Although it is unclear how 
discrepant intention and actual uptake will be in the context of genetic testing for prostate 
cancer, the discrepancy has been reported in studies of intention and uptake for both 
breast and colon cancer. In fact, in a review of such investigations, Lerman and Shields 
(2004) note that approximately 80% of individuals who are offered an opportunity to 
undergo testing state that they will undergo testing, but that when they are presented with 
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the actual test situation, actual uptake is approximately 50%. It is therefore important to 
consider that this discrepancy is likely to be seen with genetic testing for prostate cancer 
risk when the test becomes available, and that it might be accounted for by both social 
desirability and by intervening variables not explored in the present investigation. 
Finally, an additional limitation of this study is the use of archival data. This 
limits the ability of the researcher to feel control over how the study was conducted. 
Fortunately, this investigation was well-conducted, administration of the questionnaire 
was standardized, and the methodology was sound.  
 
Future Research 
To follow up the present study, research more closely targeting the constructs in 
the health belief model would help to enhance the knowledge gained in this investigation. 
This would incorporate not only perceived benefits and perceived barriers/possible 
negative consequences, but also perceived susceptibility to carrying a mutation, perceived 
severity of carrying the disease risk, and specific cues to action such as symptoms, mass 
media communications, or a health education campaign (van der Pligt, 1996). In this 
case, it would be of interest to investigate the impact of psychoeducational interventions 
incorporating the current insurance and employment discrimination laws, current data on 
psychological risks, information about benefits of testing, and potential negative 
outcomes on the decision-making process.  
Jacobsen et al. (1997) found that women who perceived more benefits than 
negatives to genetic testing for breast cancer were more inclined to state intention to 
undergo testing for mutations. A study of patients’ intention to undergo colon cancer 
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genetic testing indicates that when perceived benefits outweigh costs, individuals are 
more likely to undergo genetic testing (Vernon et al., 1999).  Vernon et al. (1999) also 
note that positive aspects such as perceived benefits of testing were more strongly 
associated with intention to undergo testing than were negative aspects. Given these 
findings, and the results of this study which indicate that beliefs in benefits of testing 
appear to outweigh the influence of concerns about consequences, future research might 
incorporate a decision tool, through which a better understanding of the decision-making 
mechanism might be elucidated. A decision tool might be built and tailored to the 
specific population based on multi-attribute utility measurement and on maximization of 
expected utility of testing (Edwards, 1998).  
In addition to the inclusion of a decision tool and the constructs incorporated in 
the health belief model, further investigation of the impact of demographic variables and 
health related quality of life in investigations targeting a high risk population would 
enhance the current understanding of the decision-making process. Given the result 
suggesting that men with less education are more inclined to undergo testing, while level 
of income exhibits the opposite effect, future studies should continue to investigate the 
impact of both variables, given that, in general, wealthier men tend to be more educated, 
as evidenced by the observed covariance between income and education in the present 
study. Given the significant indirect influence of HRQL in the current investigation, 
further research will help to further clarify whether this result is generalizable.  
Future research might also address differences in decision-making between ethnic 
groups, particularly focusing on African American men in order to help inform 
interventions for this high risk group. African American men are known to be the least 
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likely ethnic group to engage in prostate cancer screening (Weinrich et al., 1998). Since 
African American men have been shown to have higher incidence of prostate cancer and 
they have higher mortality rates than Caucasian men, this is particularly relevant to 
accomplishing the goals of genetic testing, as it appears likely that African American men 
would also be less likely to engage in genetic testing. An investigation of test motivation 
for BRCA1 testing following pretest education found that African-American women at 
low to moderate risk might be motivated to test by education and counseling (Lerman et 
al., 1999). This finding differed from that of the Caucasian cohort, in which there was no 
difference in motivation to test based on education and counseling (Lerman, et al., 1999).  
Thus pretest education for African American men should be investigated as a way to 
increase participation in genetic testing protocols.  
Although social influence did not appear to be adequately assessed in this study, 
influence continues to be relevant to decision-making for prostate cancer genetic testing. 
People evaluate information rationally and thoughtfully, and values are normatively 
established (Deutsch & Gerrard, 1955). Thus, normative influence incorporates a desire 
to gain approval and avoid rejection. It typically involves compliance or going along with 
other’s requests despite private disagreement, and is related to ideas of peer-group 
pressure most commonly associated with social groups (Deutsch & Gerrard, 1955). The 
Commitment/Influence variable in the present investigation appears to tap into this 
construct, and to strongly influence decision-making, but future investigations should 
include a more carefully constructed measure that more closely assesses this construct. 
Of particular relevance would be assessments of members of the social network (e.g., 
spouse, doctor, and children) in order to more completely assess level of influence from 
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multiple sources.  It appears likely that when influence is more adequately assessed, 
family and social network will be found to play a role in the decision-making process and 
to be particularly relevant to genetic counseling protocols. 
 In addition, other environmental variables might be addressed in future 
investigations. For example, ease of obtaining the test was not assessed in the present 
investigation. Future investigations might compare different scenarios in order to 
determine a set of circumstances in which men would be likely to submit to testing. One 
potential scenario would be to compare free screening and screening that might be 
covered by insurance or be paid for out of pocket. Another might incorporate screening in 
the workplace as compared to in a hospital clinic. These comparisons might uncover 
barriers to testing, thereby helping to guide the development of methods to increase 
participation in screening.  
Finally, future studies might test the current and similar models both before and 
after the recommended pre-test counseling, in order to determine the stability of men’s 
commitment to test intention, and the impact of obtaining more information about the 
risks, benefits and potential outcomes of testing. This would likely provide a clearer 
understanding of the decision-making process and the influence of standard counseling 
protocols on men’s decision-making once the test becomes available. 
 
Clinical Implications 
Although the present study has some limitations, there are also some significant 
implications in the findings. The primary goal of genetic testing for cancer is to help 
cancer prevention efforts in more susceptible populations by improving monitoring and 
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screening, in addition to improving the dissemination of information about benefits of 
prophylactic surgery and chemoprevention, in order to reduce the number of cancer 
deaths (Bowen et al., 1999). Thus, the ideal outcome and primary goal of genetic testing 
is behavior change that would lead to earlier detection and better health outcomes 
(Lerman et al., 2002). 
The results of this study have the potential to benefit patients, physicians, and 
their families as they are faced with deciding how much information they would like to 
know about their future health. In addition, concerns about potential emotional 
consequences of testing, as well as concern about insurance and finances will be helpful 
in guiding pre- and post-test counseling interventions as well as the informed consent 
process.  
Results from the present study suggest a need to offer psychoeducational services 
to men presented with the option to undergo genetic testing for prostate cancer and their 
families. In the present study, the degree of influence from family members and other 
members of the social network is unclear, but it is likely that family members should be 
included in the counseling process given the familial nature of genetic testing and the fact 
that the impact of test results will likely be felt by a number of family members. 
The delivery of genetic counseling and psychological services for men presented 
with the opportunity to test for mutations related to prostate cancer may be best provided 
through multidisciplinary collaboration with urologists, genetic counselors, primary care 
physicians, and psychologists. Urologists and family care physicians may be able to 
identify men at high risk for prostate cancer and make the referral for pretest counseling. 
Genetic counselors will be able to provide information about testing and the implications 
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of its results, and they could use the general model developed in this and future studies to 
determine the need to refer to psychologists for intervention related to family 
interactions, concerns about consequences, potential psychological consequences, and to 
help with decision-making.    
The role of psychologists in the field of genetic counseling is only peripheral at 
this time, and psychologists are not yet core members of the genetic testing team (Saab, 
P.G., McCalla, J.R., Coons, H.L., Christensen, A.J., Kaplan, R., Stepanski, E., Krantz, 
D.S., & Melamed, B., 2004). However, as genetic testing becomes more widely 
available, it is likely that this involvement will increase. One current concern is that 
seemingly subtle changes in familial and individual adjustment both during the decision-
making process and after testing may not be easily identified by medical professionals or 
genetic counselors, and, as a result, these men would not receive the psychological 
attention that might maximize decision-making and adjustment to receipt of results of 
testing. The inclusion of a health psychologist on the genetic testing team would provide 
the clinician with an opportunity to interact with the patients and their spouses, and, 
through this interaction and communication with the team of physicians and genetic 
counselors, identify men who might require supportive services. In addition, patients are 
more likely to be willing to utilize psychological services if psychologists are included as 
standard participants in testing protocols.  
Ultimately, psychological services targeting both the individual and family would 
likely help more men make more informed decisions for themselves and for their 
families, and it might help to increase the vigilance likely required to help men discover 
cancer earlier, thereby reducing the risk of fatality. According to the final model in this 
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study, primary targets for intervention will be younger, more educated, lower income 
men with poorer health related quality of life. These men are likely to have more 
concerns about consequences and to be less committed to their decisions. Clinical 
services should be psychoeducational in nature, and they should focus on maximizing the 
understanding of benefits of testing, presenting the reality of insurance and employment 
laws, and helping people to understand that their concerns about psychological 
consequences are unlikely to become a reality given the experience of people who have 
participated in other genetic testing protocols.    Future research, as discussed above will 
likely help identify additional targets for intervention in order to more finely tune the role 
of the psychologist in genetic testing/counseling protocols.  
It will be encouraging for professionals considering the potential for widespread 
genetic testing for high risk families and in the distant future, the general population, to 
see that the level of interest in the general population is very high (Lerman & Shields, 
2004). Although there is research suggesting that there is potential for clinically 
significant levels of distress after testing, it is encouraging that the emerging literature 
suggests that this distress does not sustain itself at follow-up (Bratt et al., 2003; Coyne et 
al., 2003). Although concern about the potential for psychological consequences of 
testing can be perceived as a barrier to testing, educational interventions are likely to help 
modify this concern. In a study specific to men’s screening for prostate cancer, 
researchers found that most men with a high risk for developing prostate cancer did not 
experience any severe adverse psychological effects after screening (Bratt et al., 2003). 
However, it will be important for genetic counselors to include information about 
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psychological risk during the informed consent process in order to aid in decision-making 
and perhaps to increase participation.  
This model suggests several policy implications regarding requirements for 
genetic consultation as well. As part of the informed consent process, it will be important 
to include a discussion about the importance of including family members in the 
decision-making process, with particular regard to the potential benefits and 
consequences of testing for both the individual and family. It is important to educate men 
about the realities of insurance discrimination and the current relevant laws. Regarding 
other potential concerns, a clear explanation of the potential psychological consequences 
of testing should be provided along with a detailed description about potential benefits. 
This expands the current genetic consultation recommendations, which emphasize the 
dissemination of family risk and pedigree analysis with little regard to beliefs, concerns, 
background factors, or the influence of family members noted in this investigation 
(ASCO, 2003).   
The importance of the informed consent process must be stressed in light of the 
high level of enthusiasm for testing reported in the general population. Large-scale 
population-based genetic testing is many years off, while testing for high risk individuals 
appears to be on the horizon (Collins et al., 2003; Saab et al., 2004; Lerman & Shields, 
2004).  As stated previously, provision of information about the potential benefits of 
testing should be considered standard in the informed consent process. It should be 
explained that there are in fact risks (e.g., insurance/employment) of testing that must be 
considered. In addition, it is important to incorporate basic facts about what testing can 
and cannot do. For example, a genetic test for prostate cancer genes cannot guarantee that 
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a person will or will not develop the disease. The test, along with family history, would 
likely only indicate level of risk of developing prostate cancer (McCabe & McCabe, 
2004). Thus, a negative test does not render a person free of risk for the disease, 
particularly if they have at least one first-degree relative who was diagnosed with prostate 
cancer. Dissemination of risk information in genetic testing protocols  is particularly 
important because testing could potentially end up being more harmful than helpful if the 
patient is not prepared for financial or psychological consequences, and if they are 
unprepared to manage the results of testing.  
Regarding test results, it is likely that men will be interested in obtaining 
information about benefits of testing in addition to gaining knowledge about relative risk. 
Although there is no specific preventive treatment currently available for high risk men, 
recommendations include watchful waiting and regular screening. This will be 
particularly relevant in high risk younger men, who would likely not attend regular 
screenings under the age of 50. In addition, ongoing investigations are testing other 
preventive measures. One such investigation has found that a medication named Proscar 
(also known as Propecia), which is primarily used to treat male-pattern baldness, reduced 
the prostate cancer incidence by 25% compared to a placebo over a seven–year period 
(Thompson, Goodman, & Tangen, 2003). It will be particularly relevant for members of 
genetic testing teams to be aware of scientific developments, and to disseminate relevant 
preventive information accordingly. 
Finally, the traditional approach to the provision of genetic counseling has been 
non-directive (Bennett, Hampel, Mandell, & Marks, 2003). However, given the results of 
this study, a more directive, collaborative, psychoeducational approach appears to be 
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indicated, given the need to provide detailed information about risks and benefits as 
discussed previously. Fortunately, the American Society of Clinical Oncologists (ASCO) 
strongly recommends that genetic testing be paired with both pre- and post-test 
counseling and their recommendations are consistent with those presented in this 
investigation. ASCO recommends that implications of both positive and negative tests be 
discussed, and they recommend explaining that the test results might not be informative. 
In addition, they suggest that psychological risks and benefits be presented along with the 
risks for insurance and employment discrimination. They also stress the importance of 
sharing genetic test results with at-risk family members (ASCO, 2003). Although ASCO 
does not make specific recommendations for the type of counseling approach, it does 
appear, based on the degree of education and information that they suggest be provided, 
that the collaborative psychoeducational approach suggested by this investigation would 
support the ASCO recommendations.  
 
Conclusions 
 The present study investigated the influence of background demographic 
characteristics and belief variables on men’s intention to undergo genetic testing for 
prostate cancer.  Men in this study primarily stated that they would undergo testing when 
the test becomes available. The primary proximal predictors of intention to undergo 
testing were belief in the benefits of testing, the tendency to commit to one’s decisions 
and resist influence from others, and concern about consequences of testing. As 
predicted, background characteristics such as age, education, and income, indirectly 
influenced men’s decisions; and men’s beliefs, commitment to their beliefs, and concern 
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about consequences directly influenced their decision to test. Family history was not 
found to strongly influence intention, but it is likely that it would be influential in future 
studies in which participants are selected for strong family history. As predicted, health 
related quality of life did not directly influence intention, but it did contribute a 
significant indirect influence. In addition, this study yielded a model from which to 
launch further investigations to guide clinical interventions for men engaged in the 
decision-making process when prostate cancer genetic testing becomes available. Of 
significant interest is finding a sufficiently robust way to measure social influence, so that 
it can be adequately understood relative to decision-making, as it has strong potential to 
play an important role as a target for counseling.  
The results of this investigation suggest important implications for clinical 
intervention and future research, particularly in the context of the unique challenges 
individuals faced with the potential to learn about their familial and personal genetic 
predispositions and the psychosocial impact of the decision to learn such information.  
The present model shows that when the test becomes available, interest in 
undergoing testing will likely be high, thereby providing the opportunity to engage men 
in the pre-test counseling process. In addition, the final model in this study can 
potentially help to identify men who require more intervention or education, and it 
provides a more meaningful and relevant model of predictors of intention to undergo 
testing. This will be a useful tool with which to guide both future research and ultimately 
the clinical practice of primary care physicians, psychologists, urologists, and genetic 
counselors.   
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APPENDIX A: PATIENT DEMOGRAPHICS 
 
All responses were by telephone survey. Questions were repeated if clarification was 
requested.  
1) In what year were you born? _______________________ 
2) Has anyone in your family had prostate cancer? Yes (1)       No (2)  
3) How many years of school did you complete? ___________________  
4) What is your household’s approximate yearly income?  
            (1) $15,000 or less 
            (2) More than $15,000 and not more than $45,000 
            (3) More than $45,000 and not more than $75,000 
            (4) More than $75,000 and not more than $105,000 
            (5) More than $105,000 
 
5) What is your ethnic background?     
(1) Caucasian/ Non-Hispanic White 
(2) African American        
(3) Hispanic 
(4) Asian  
(5) Native American  
(6) Other _____________________ 
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APPENDIX B: BELIEFS 
 
 
These statements are rated on the following scale: 
(5) Strongly agree 
(4) Agree 
(3) Neutral; neither agree nor disagree 
(2) Disagree 
            (1) Strongly disagree 
 
Beliefs about Benefits 
1) If I don’t have the prostate cancer risk gene, I will be able to put my mind at rest about   
prostate cancer.  
2) No matter my results, I would want testing if it helps find a cure. 
3) I believe this test could save my life. 
4) The test results might provide valuable information on prostate cancer risk to my 
family members.  
 
Concern 
Psychological 
1) If I know I have the prostate cancer risk, I will feel worse about myself. 
2) If I know I have the prostate cancer risk gene, it will make me anxious.  
3) If I know I have the prostate cancer risk gene, it will make me want to end my life. 
4) If I know I have the prostate cancer risk gene, it will make me feel guilty.  
5) If I know I have the prostate cancer risk gene, it will change the way I think about the 
future.  
 
Insurance/Employment 
6) I am concerned I will lose or not be able to get health insurance if I get the genetic test 
for prostate cancer risk. 
7) I am concerned I will lose or not be able to get life insurance if I get the genetic test for 
prostate cancer risk.  
8) I will not be able to keep my job, or get a promotion, if I know I have the prostate 
cancer gene.  
 
Commitment/Influence 
Spouse 
1) Even if my wife or partner did not want me to, I would get genetic testing. 
Family  
2) Even if my children did not want me to, I would get genetic testing. 
3) Even if other relatives did not want me to, I would get genetic testing. 
Other 
4) Even if my doctor recommended against it, I would get genetic testing. 
5) Even if my friends did not want me to, I would get genetic testing.  
6) Even if a genetic testing specialist recommended against it, I would get genetic testing.  
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APPENDIX C: INTENT  
 
 
All responses were rated on the following scale: 
(5) Definitely Yes 
(4) Probably Yes 
(3) Not Sure 
(2) Probably No 
(1) Definitely No  
 
1) (Primary Intent Statement) I would want the genetic test for prostate cancer risk when 
it becomes available.  
 
2) I would want this test even if it does not tell me new information about how early or 
aggressive prostate cancer might be in my future. 
 
3) I would want this test if it could tell me that prostate cancer is more likely to be more 
life-threatening because I have the prostate cancer risk gene. 
 
4)  I would want this test if it could tell me that prostate cancer is more likely to happen 
earlier in my life.   
 
5) No matter my results, I would want testing if it helps find a cure. 
 
6)  I would want to get tested because I just want to know if I have the gene for prostate 
cancer risk. 
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APPENDIX D: OVERALL GOODNESS OF FIT INDICES FOR SEM 
 
 
Goodness of Fit Measures Brief Description Levels of 
Acceptable Fit 
Absolute Fit Measures Extent to which overall model 
predicts observed covariances. 
They do not use an alternative 
model for comparisons. 
 
Chi Square (χ2)a Statistical test of significance 
provided. Want to fail to reject 
the null. Should be non-
significant 
Smaller is better , 
and ratio of χ2 to 
DF should be < 2 
Goodness of Fit Index (GFI) Compares the model’s 
predictions with the observed 
data. Represents overall fit. 
Higher values 
indicate better fit 
≥.90 
Root Mean Square Error of 
Approximation (RMSEA) 
Average difference per degree of 
freedom expected to occur in the 
population, not the sample 
Acceptable values 
<.08 , preferable 
<.06 
Incremental Fit Measures Extent to which the specified 
model performs better than the 
baseline model w/ no factors. 
 
Adjusted Goodness of Fit 
Index (AGFI) 
Associated with just-identified 
models  
Larger is better  
≥.90 
Comparative Fit Index (CFI) Comparative measure 
benchmarked against a null 
model 
Larger is better 
≥.90 
Normed Fit Index (NFI)  Relative comparison of proposed 
model to null model. More 
covariance accounted for with 
higher values 
Larger is better 
≥.90 
Parsimonious Fit 
Measuresb 
Accounts for Degrees of 
Freedom necessary to achieve fit 
 
Akaike Information Criterion 
(AIC) 
Penalizes for model complexity, 
reflects discrepancy between 
proposed and observed 
Values closer to 
0, lower values 
are better 
Parsimonious Normed Fit 
Index (PNFI) 
Used to compare proposed 
model to null model  
Higher values 
indicate better fit 
Parsimonious Goodness of 
Fit Index (PGFI) 
Compares model’s predictions to 
observed model accounting for 
model complexity 
Higher values 
indicate better fit 
aχ2 is not an ideal test of model fit because it is affected by sample size(e.g., > sample size implies  > 
potential for Type I error)  and there is always some lack of fit due to omitted variables. It should be 
considered in combination with other fit statistics.  bParsimonious fit indices penalize more complex 
models. It favors simpler models and should not be used alone to determine model fit. Model fit should be 
considered separately and these indices should be considered when comparing models. 
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